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ABSTRACT
Salmonella is one of the most commonly reported foodborne pathogens and enterohaemorrhagic 
Escherichia coli (EHEC) is one of the most dangerous. Th ey both spread by zoonotic and 
person-to-person transmission routes. Most Salmonella infections are characterized by mild-
to-moderate self-limited diarrhea but also serious disease resulting in death has been reported. 
Bloody diarrhea is a common symptom of human EHEC infection and the infection may 
lead to severe post-infection disease such as hemolytic uremic syndrome (HUS), thrombotic 
thrombocytopenic purpura (TTP) and even death. 
Th e purpose of this thesis was to investigate the diversity of Salmonella and EHEC strains 
isolated from domestically acquired infections using several pheno- and genotyping methods 
for surveillance and outbreak investigation purposes as well as evaluate certain epidemiological 
typing methods in Finland. All Salmonella and EHEC isolates of domestic origin during 2007-
2014 in Finland were studied. Serotyping, phage typing, antimicrobial susceptibility testing, 
phenotype microarray, pulsed-fi eld gel electrophoresis (PFGE) and multilocus variable-number 
tandem repeat analysis (MLVA) were applied as epidemiological typing tools for Salmonella 
isolates. EHEC isolates were analyzed using serotyping, phage typing, antimicrobial susceptibility 
testing, virulence gene detection (stx1, stx2, eae, hlyA and saa) and PFGE.
During the study period, the number of domestically acquired Salmonella infections has 
decreased about one fi ft h compared to the previous decade whereas the number of domestic 
EHEC infections have increased about one third. Th e incidence of Salmonella infections was 
highest in 2012 (7.5/105 population) and lowest in 2014 (5.4/105 population). Th e incidence 
of EHEC infections was highest in 2013 (0.33/105 population) and lowest in 2008 (0.07/105 
population). 15% of all Salmonella strains and 70% of all EHEC strains were considered 
domestically acquired. A total of 131 diff erent Salmonella serovars were detected. Th e most 
common serovars were Typhimurium (32%), Enteritidis (15%) and group B (6%). Among 
Typhimurium strains, phage types DT1 (37%), RDNC (18%) and DT104 (9%) were the most 
common ones. Th e most frequently detected phage types among the domestically acquired S. 
Enteritidis infections were PT8 (17%), PT1B (14%) and PT4 (13%). Th e majority of domestic 
Typhimurium and Enteritidis (60%) strains were susceptible to tested antimicrobials. During the 
study period, a total of 188 infections caused by EHEC were detected. Most of them were caused 
by serotype O157:H7 (60%). Th e majority of O157 strains (63%) were unable to ferment sorbitol. 
PT8 was the most common phage type among the sorbitol-negative and PT88 among sorbitol-
positive O157 strains. Among non-O157, 22 distinct O:H serotypes were detected. Th e most 
common ones were O26:H11, O103:H2 and O145:H-. Th e majority of domestic EHEC strains 
(81%) were susceptible to all tested antimicrobials: 96% of O157:H7/H- and 60% of non-O157 
strains.  All O157 strains carried stx2 (40% in combination with stx1), eae and hlyA genes. In 
contrast, 55% of non-O157 stains had stx1 gene and 76% carried eae and hlyA genes.
Th e MLVA method was found to be a powerful epidemiological tool for S. Typhimurium with 
discriminatory power similar to PFGE. In addition, MLVA was faster, cheaper and the results 
were easier to compare between laboratories. Th e domestic S. Typhimurium strains were divided 
into 170 distinct MLVA types (diversity index 0.891). In MLVA, the three most common profi les 
(3-16-NA-NA-0311, 3-15-NA-NA-0311 and 3-17-NA-NA-0311) counted for 47% of the strains 
showing that the lack of locus STTR6 and locus STTR10p was characteristic for domestic S. 
Typhimurium. However, XbaI-PFGE remains a useful genotyping method for investigations 
of other Salmonella serovars and EHEC strains. Th e interpretation of XbaI-PFGE profi les can 
be challenging as demonstrated by a Finnish nationwide outbreak caused by S. Newport and 
S. Reading -contaminated iceberg lettuce. Th e S. Reading strains had four diff erent XbaI-PFGE 
profi les. Based on epidemiological information, all these diff erent variants of the outbreak 
causing strains were considered as outbreak-related.
Th e sources of the most EHEC outbreaks remained undetermined. In one out four EHEC O157 
outbreaks, unpasteurized milk was found as the source of the infections. Although 40% of the 
domestic EHEC strains were non-O157, only strains of serogroup O157 caused outbreaks in 
Finland. However, non-O157 strains caused several family clusters and were linked with HUS. In 
2009, a sorbitol-fermenting EHEC O78:H-:stx1c:hlyA was detected in blood and fecal samples of a 
neonate. Th is EHEC serotype had not been seen in Finland prior to this family-related outbreak 
and bacteremia caused by EHEC is exceptionally rare.
Taken together, Salmonella and EHEC infections are a major public health concern. Th is thesis 
provides new information about the characteristics of Salmonella and EHEC strains isolated from 
domestically acquired infections in Finland and evidence that eff ective surveillance is needed for 
early detection and prevention of the spread of Salmonella and EHEC infections. In particular, 
typing methods used should be internationally harmonized and the results made comparable.
TIIVISTELMÄ
Salmonella on yksi yleisimmistä elintarvikevälitteisistä bakteeripatogeeneistä, 
enterohemorraaginen Escherichia coli (EHEC) yksi vaarallisimmista. Molemmat bakteerit 
ovat eläimen ja ihmisen välityksellä leviäviä ja tarttuvat myös henkilöstä toiseen. Useimmat 
salmonellojen aiheuttamat infektiot ovat lieviä, itsestään parantuvia suolistoinfektioita, mutta 
myös vakavia, kuolemaan johtavia tartuntoja todetaan. Veriripuli on yleinen oire erityisesti 
pikkulasten EHEC-infektiossa. Infektio saattaa johtaa myös vakaviin jälkitauteihin kuten 
hemolyyttisureemiseen oireyhtymään (HUS), tromboottiseen trombosytopeeniseen purppuraan 
(TTP) ja jopa kuolemaan. 
Tässä työssä tutkittiin salmonella- ja EHEC-kantojen ominaisuuksia useilla ilmiasuun 
(fenotyyppi) ja perimään (genotyyppi) perustuvilla menetelmillä. Lisäksi selvitettiin tiettyjen 
genotyypitysmenetelmien soveltuvuutta epidemiologiseen seurantaan ja tartuntalähteiden 
jäljittämiseen. Erityisesti oltiin kiinnostuneita niistä salmonella- ja EHEC-kannoista, joiden 
tartunta oli saatu Suomessa. Tutkimus käsitti kaikki kotimaiset vuosina 2007-2014 eristetyt 
salmonella- ja EHEC-kannat. Salmonella-kantojen epidemiologiseen tyypittämiseen käytettiin 
neljää fenotyypitysmenetelmää, serotyypitystä, faagityypitystä, mikrobilääkeherkkyysmääritystä 
ja mikroarray testiä sekä kahta genotyypitysmenetelmää, pulssikenttägeelielektroforeesiä 
(PFGE) ja multilocus variable-number tandem repeat analysis (MLVA) testiä. EHEC-kantojen 
tyypitykseen käytettiin O:H-serotyypitystä, faagityypitystä, mikrobilääkeherkkyysmääritystä, 
virulenssigeenien määritystä (stx1, stx2, eae, hlyA and saa) ja PFGE -menetelmää.
Tutkimusaikavälillä kotimaassa saatujen salmonellainfektioiden määrä laski noin viidenneksen 
verrattuna edelliseen vuosikymmeneen kun taas EHEC-tartuntojen lukumäärä nousi noin 
kolmanneksen. Kotimaisten salmonellatartuntojen ilmaantuvuus oli korkeimmillaan vuonna 
2012 (7.5/105 asukasta) ja alimmillaan vuonna 2014 (5.4/105 asukasta). Kotimaisten EHEC-
infektioiden ilmaantuvuus oli korkein vuonna 2013 (0.33/105 asukasta) ja matalin vuonna 
2008 (0.07/105 asukasta). Kaikista salmonellatartunnoista 15 % ja EHEC-tartunnoista 70 % oli 
kotimaista alkuperää. Kotimaisia salmonellatartuntoja aiheutti yhteensä 131 eri serotyyppiä. 
Niistä yleisimmät olivat Typhimurium (32 %), Enteritidis (15 %) ja ryhmä B (6 %). Kotimaisten 
S. Typhimurium -kantojen yleisimmät faagityypit olivat FT1 (37 %), NST (18 %) ja FT104 (9 
%). Kotimaista alkuperää olevien S. Enteritidis -kantojen yleisimmät faagityypit olivat FT8 (17 
%), FT1B (14 %) ja FT4 (13 %). Suurin osa kotimaisista Typhimurium- (60 %) ja Enteritidis-
kannoista (60 %) olivat herkkiä testatuille mikrobilääkkeille. Tutkimusaikavälillä todettiin 188 
EHEC-tartuntaa, joista valtaosan aiheutti serotyyppi O157:H7 (60 %). Suurin osa EHEC O157 
-kannoista (63 %) oli sorbitoli-negatiivisia. Faagityyppi FT8 oli yleisin sorbitoli-negatiivisten 
ja faagityyppi FT88 sorbitoli-positiivisten O157 kantojen keskuudessa. Non-O157 kannat 
tyypittyivät yhteensä 22 eri O:H serotyyppiin. Yleisimmät non-O157 serotyypit olivat O26:H11, 
O103:H2 ja O145:H-. Suurin osa kotimaista alkuperää olevista EHEC-kannoista (81 %) oli 
herkkiä testatuille mikrobilääkkeille: 96 % kaikista O157:H7 ja 60 % non-O157 kannoista. Kaikki 
O157 -kannat kantoivat geenejä stx2 (40 %:lla kannoista oli myös stx1 geeni), eae ja hlyA kun taas 
valtaosa non-O157 kannoista kantoi geeniä stx1 (55 %) ja 76 %:lla kannoista oli geenit eae ja hlyA.
MLVA -menetelmä osoittautui toimivaksi epidemiologiseksi tyypitysmenetelmäksi, ja sen 
erottelukyky oli yhtä hyvä kuin aiemmin käytetyn PFGE -menetelmän. Lisäksi MLVA oli 
nopeampi ja halvempi kuin PGFE menetelmä ja tulokset olivat helpommin kansainvälisesti 
vertailtavissa. Kotimaista alkuperää olevat S. Typhimurium -kannat jakaantuivat 170 eri MLVA- 
tyyppiin (diversiteetti-indeksi 0,891). Noin puolet (47 %) kannoista kuului kolmeen yleisimpään 
MLVA -tyyppiin (3-16-NA-NA-0311, 3-15-NA-NA-0311 ja 3-17-NA-NA-0311). Lokuksien 
STTR6 ja STTR10p puuttuminen oli tyypillistä kotoperäisille S. Typhimurium -kannoille. 
XbaI-PFGE oli kuitenkin hyödyllinen menetelmä muiden salmonellan serotyyppien ja EHEC 
-kantojen genotyypittämiseen. XbaI-PFGE tulosten tulkitseminen saattaa olla haastavaa, minkä 
myös maanlaajuinen S. Newport/S. Reading -epidemia vuonna 2009 havainnollisti. Kyseisessä 
epidemiassa S. Reading kannat jakaantuivat neljään eri PFGE -tyyppiin, joiden kuitenkin 
katsottiin epidemiologiseen tietoon perustuen liittyvän samaan epidemiaan. 
Useimpien EHEC-epidemioiden lähteet jäivät tuntemattomiksi. Tutkimusaikavälillä havaittiin 
neljä EHEC -bakteerin aiheuttamaa epidemiaa ja useita perheensisäisiä rypäitä, joista yhdessä 
lähteeksi todettiin pastöroimaton maito. Vaikka 40 % kaikista kotoperäisistä EHEC -infektioista 
oli non-O157 serotyyppien aiheuttamia, vain serotyyppi O157 aiheutti epidemioita Suomessa. 
Non-O157 kannat aiheuttivat kuitenkin perheensisäisiä tartuntoja ja yhdistettiin vakaviin 
jälkitauteihin (HUS). Vuonna 2009 sorbitoli-positiivinen EHEC O78:H-:stx1c:hlyA eristettiin 
vastasyntyneen verestä ja ulosteesta. Kyseistä serotyyppiä ei ollut havaittu Suomessa aikaisemmin 
ja EHEC -bakteerin aiheuttamat verenmyrkytykset ovat kansainvälisestikin erittäin harvinaisia. 
Salmonella ja EHEC aiheuttavat merkittäviä kansanterveysongelmia. Tässä työssä saatiin 
merkittävää uutta tietoa Suomessa todettujen kotimaista alkuperää olevien salmonella- ja 
EHEC-infektioiden aiheuttajabakteereiden ominaisuuksista. Tehokas salmonella- ja EHEC 
-seuranta auttaa havaitsemaan alkavat epidemiat ja estämään niiden leviämisen. Erityisesti uusia 
tutkimusmenetelmiä kehitettäessä tulisi huomioida, että tyypitysmenetelmä on kansainvälisesti 
harmonisoitu ja tulokset vertailukelpoisia. 
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11  INTRODUCTION
Salmonella enterica and enterohemorrhagic Escherichia coli (EHEC) are important foodborne 
bacteria and infections spread via contaminated food and water that make millions of people ill 
worldwide annually [1, 2]. Th ese bacteria are spread by zoonotic transmission route or through 
direct person-to-person contact causing gastrointestinal infections in humans [3, 4]. Th e 
consequence of these infections is a serious impact on the economy in terms of lost productivity 
and medical expenses. Aft er Campylobacter, Salmonella infections are the most common cause of 
diarrheal diseases in the industrialized countries while EHEC infections are rare but oft en linked 
with severe disease and sequelae [5, 6]. Various serovars of S. enterica cause about 2,000 infections 
in Finland yearly; of them, 15-20% are considered of domestic origin. Serovars Typhimurium 
and Enteritidis are the most common [7]. Symptoms of salmonellosis range from a self-limiting 
mild diarrhea to severe bacteremia and infections might be fatal especially to infants, the elderly 
and immunocompromised individuals [8]. In addition, even asymptomatic infections may result 
in post-infectious complications such as reactive arthritis. In contrast to Salmonella infections, 
only about 10-100 EHEC infections are detected annually in Finland. Of them, the majority (ca. 
80%) are considered domestically acquired [7]. Th e main symptoms of EHEC infections are 
watery and bloody diarrhea but the disease may progress to severe post-infectious complications 
such as hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP) and 
even death [4]. 
Th e overall annual number of Salmonella infections has decreased. However, incidence has 
increased for some domestic serovars and decreased for others. Presumably at least some of the 
domestic cases have been associated with contaminated imported foodstuff s, changes in human 
lifestyle and industry. In contrast to the declining trend of Salmonella infections, the numbers of 
EHEC infections have risen. Although Salmonella and EHEC can cause foodborne outbreaks, the 
majority of the reported cases are sporadic [9]. Th e sources and transmission routes of previous 
domestic cases of gastrointestinal disease have remained largely unknown. Th erefore, in order 
to monitor changes among domestic foodborne bacteria, to detect family-related clusters and 
large outbreaks, and to compare bacterial genotypes internationally, accurate and internationally 
harmonized typing methods are required. 
Th e purpose of this study was to characterize domestic Salmonella and EHEC strains in detail 
using several pheno- and genotypic methods and trace back the sources of human infections. 
Several typing methods were designed and set up. Th e study aimed also to evaluate typing 
methods for routine use in reference laboratories and for epidemiological outbreak investigations. 
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2.1  Nomenclature, classi? ca? on and general characteris? cs of 
Salmonella
Th e history of the Salmonella species dates back to 1885, when the organism today known as 
Salmonella was fi rst isolated from pigs by Dr. D.E. Salmon and Dr. T. Smith [10]. Later in 1896, 
Dr. F.M. Widal found that the serum of a typhoid patient agglutinated the typhoid bacillus which 
was the base for the serological diagnosis of Salmonella Typhi infection in humans [11]. Initially, 
the bacterium was named in honor of Dr. Salmon by Ligniéres in 1900. Th e nomenclature for the 
genus Salmonella is complex because of the ever-changing nomenclature system, newly detected 
species and diff erent systems used to refer to this genus [12]. Th e Salmonella nomenclature has 
evolved over time and at the early stages each Salmonella serovar was considered a separate 
species [13]. However, this one serovar – one species concept was found to be misleading since 
most serovars cannot be distinguished by biochemical tests. Various other taxonomy proposals 
have been made based on the clinical role of the diff erent strains, their biochemical characteristics 
and their genomic relatedness [14-17] leading to the current nomenclature system with only 
two species including more than 2,600 serovars [18] which are distinguished by antibody 
interactions with the somatic O and fl agellar H and in some cases capsular polysaccharides (Vi 
antigen) surface antigens. Th e exact reasons for this high level of surface-antigen diversity are 
still unknown. In order to avoid confusion between Salmonella serovars and species, the name 
of the serovar starts with a capital letter and is not italicized. Th e former S. typhimurium is now 
written in the form S. enterica supsp. enterica serovar Typhimurium or briefl y S. Typhimurium. 
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Domain 
Phylym 
Class 
Order 
Family 
Genus 
Species 
Subspecies/ 
Pathogroups 
S. bongori 
S. enterica subsp. enterica 
S. enterica subsp. salamae 
S. enterica subsp. arizonae 
S. enterica subsp. diarizonae 
S. enterica subsp. houtenae 
S. enterica subsp. indica 
EHEC 
EIEC 
EPEC 
ETEC 
EAEC 
DAEC 
 others 
Commensal 
E. coli  
Bacteria 
Proteobacteria 
Gammaproteobacteria 
Enterobacteriales 
Enterobacteriaceae 
S. enterica 
MAEC 
UPEC 
E. coli 
Diarrheagenic 
E. coli 
Extraintestinal  
E. coli 
Escherichia Salmonella 
Figure 1: Taxonomy of Salmonella and Escherichia coli species. 
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Salmonella species belong to the same proteobacterial family as e.g. Escherichia coli, Shigella, 
Yersinia and others in the family of Enterobacteriaceae (Fig. 1). Salmonella diverged from E. 
coli approximately 100-160 million years ago and acquired the ability to invade host cells [20, 
21]. According to current taxonomy, the genus of Salmonella is divided into two species, S. 
enterica and S. bongori (Table 1). Th e species S. enterica is further subdivided into six subspecies 
named (or numbered) as follows: S. enterica subsp. enterica (I), S. enterica subsp. salamae (II), 
S. enterica subsp. arizonae (IIIa), S. enterica subsp. diarizonae (IIIb), S. enterica subsp. houtenae 
(IV), and S. enterica subsp. indica (VI) [22]. Of these six subspecies, subspecies I is most oft en 
associated with salmonellosis in warm-blooded animals [23]. Th e other subspecies usually 
originate from cold-blooded animals and the environment [24]. Each of the subspecies contains 
multiple serovars which are listed in the White-Kauff mann-Le Minor scheme [18]. Th e World 
Health Organization (WHO) Collaborating Center for Reference and Research on Salmonella 
at the Pasteur Institute, Paris, France is responsible for updating the list when new serovars are 
recognized [18, 25, 26]. According to the current nomenclature, serovar specifi c names are only 
given to the serovars of subspecies I. Th e unnamed species of other subspecies are designated 
based on their antigenic formulas determined according to the White-Kauff mann-Le Minor 
scheme. In addition, the Salmonella strains can be divided into typhoid Salmonella and non-
typhoid Salmonella, based on clinical symptoms. Th e former strains are the causative agents 
of enteric fever and they include serovars S. Typhi and S. Paratyphi A, B, C. Th e latter group 
includes the remaining enteric Salmonella strains.
Salmonella are generally considered as facultative anaerobe, Gram-negative, motile (chicken-
adapted serovars Gallinarum and Pullorum are an exception), non-lactose fermenting, 
oxidase negative, urease negative, citrate positive and potassium cyanide negative, rod-
shaped bacteria which are about 2-5 x 0.7-1.5 μm in size [27]. Salmonella species can adapt to 
extreme environmental conditions. For example, Salmonella can grow at temperature between 
5-47°C with an optimum temperature of 35-37°C [28]. Th ey are sensitive to heat and killed at 
temperature of 70°C or higher. Salmonella grow in a pH range of 4.5 to 9.5 with an optimum 
between pH 6.5 and 7.5. Acid-adapted Salmonella species have raised a concern regarding the 
safety of fermented foods such as cured sausages and fermented raw milk products. Th ey prefer 
high water activity (aw) between 0.99 and 0.94 but can also survive at aw <0.2 as found in dried 
foods [29]. 
2.2  Salmonellosis in humans
Salmonella infections in humans are in general zoonotic, but some serovars such as S. Typhi and 
S. Paratyphi A and B colonize only humans [30]. Salmonellosis may cause signifi cant social and 
economic costs due to lost productivity and through their impact on industry and agriculture. 
Most Salmonella infections are sporadic, and only about 5-20% of them are associated with 
outbreaks [31]. Th ere is a clear seasonal trend among Salmonella infections, peaking aft er warm 
summer months [32-34]. 
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2.2.1  Risk factors and sources for Salmonella infec? ons
About 95% of human salmonellosis results from the ingestion of contaminated foods [35], 
particularly foods of animal origin such as poultry, eggs, pork, and dairy products [36-39]. 
Th e consumption of raw eggs has been especially identifi ed as the primary risk factor for 
human S. Enteritidis infection [37, 40]. In contrast to S. Enteritidis, transmission routes for S. 
Typhimurium are more diverse and less well-known. Several risk factors for S. Typhimurium 
have been identifi ed, including consumption of beef [41] pork [42], dairy products made with 
unpasteurized milk [43], exposure to animals [44] and playing in sandboxes [40]. In addition, 
imported food items have been identifi ed as the most important source for sporadic domestic 
cases, responsible for 12% of the cases in Denmark [45] and 6.4% of the cases in Sweden [46]. 
Other vehicles for salmonellosis include fresh fruits and vegetables [47-49], spices and herbs 
[50], and water [51, 52]. Also, reptiles [24], direct person-to-person transmission [53, 54] and 
direct animal contact [55] have been implicated. Also, travel has been recognized as relevant 
for the burden of human salmonellosis in countries with low levels of Salmonella in domestic 
animals including cattle, swine and poultry [9]. Unusual vehicles for human salmonellosis 
include smoked salmon [56] and certain foods with low water activity such as peanut butter [57]. 
Th e knowledge of the sources or vehicles for Salmonella infections are mostly based on case-
control studies and outbreak investigations. Th ese results are of interest because they highlight 
the multiplicity of food items and Salmonella serovars that have been associated with human 
disease.
2.2.2  Occurrence and epidemiology of Salmonella infec? ons
Salmonella infections are a signifi cant public health concern around the world [1, 58] and the 
incidences vary between 15-54 per 100,000 inhabitants in developed countries (Table 2). Only 
a small proportion of cases are detected and actually reported. According to one study, in 
industrialized countries as few as 1% of clinical cases are reported [59]. Th e annual global burden 
of non-typhoid Salmonella-mediated gastroenteritis has been estimated as high as 93.8 million 
cases, with 155,000 deaths [1]. Although more than 2,600 potentially infectious Salmonella 
serovars have been reported, most human infections are caused by limited number of serovars 
[60]. In most developed countries, the serovar Enteritidis and Typhimurium are the most 
commonly reported causatives of human salmonellosis while other serovars are more prevalent 
in specifi c regions e.g. serovars Stanley and Weltevreden in Southeast Asia [61-63]. In the United 
States (USA) alone the estimated annual incidence of Salmonella infections is approximately 1.4 
million human infections with at least 22% of cases requiring medical treatment and leading 
to 600 deaths [35]. In the USA, annual incidences of 15 illnesses per 100,000 inhabitants were 
reported in 2013 [64]. Th e three most common serovars were Enteritis (19%), Typhimurium 
(14%) and Newport (10%). In the EU, a total of 82,684 confi rmed human salmonellosis were 
reported in 2013 and an annual incidence of 20 illnesses per 100,000 inhabitants was detected 
[58].  Th is represents a decrease of salmonellosis by 8% compared to 2012. Th e incidence of 
Salmonella was lower in the whole EU level than in Finland and Sweden which might be due to 
diff erent reporting systems [7].  Particularly, a decrease in the number of S. Enteritidis has been 
reported in the EU. Of all the serovars, S. Enteritidis (40%) and S. Typhimurium (20%) were 
the most frequently reported. As a result of the harmonized reporting system and also due to 
several large outbreaks, monophasic S. Typhimurium which is an emerging variant of biphasic 
S. Typhimium lacking one fl agellar phase was the third most commonly reported serovar in the 
EU [58].
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Table 2: Incidence of Salmonella infections in certain industrialized countries.
Geographic area/
country
Incidence of 
Salmonella/100,000 
inhabitants
Major serotypes 
associated with 
human disease
Reference
Australia 54 Typhimurium, 
Enteritidis
[65]
EU* 24 Enteritidis, 
Typhimurium
[58]
Finland seperately 40 Enteritidis, 
Typhimurium
[7]
Canada 18 Enteritidis,
Typhimurium
[66]
USA 15 Enteritidis, 
Typhimurium
[67]
* Data based on 25 reporting countries from the EU including Finland
2.2.2.1  Epidemiology of S. Enteri? dis
Two major changes have occurred in the epidemiology of non-typhoidal salmonellosis during 
the 1980s and 2000s: the emergence of foodborne human infections caused by S. Enteritidis 
and by multiresistant strains of S. Typhimurium. S. Enteritidis was responsible for a worldwide 
pandemic during the 1980s and 1990s. Th e infections were associated with the consumption 
of raw or undercooked eggs and have caused large outbreaks worldwide [68, 69]. In Europe, 
about 70% of the outbreaks caused by S. Enteritidis during the 90s were related to eggs and egg 
products [70]. Th e source of the pandemic is understood to have been the rapid contamination 
of a few companies’ fl ocks and the ability of the bacterium to colonize the reproductive tract 
of the birds and infect eggs [3]. Th is theory is supported by the fact that Finland and Sweden 
which have the most extensive salmonella control programs and Australia which has strict rules 
on the import of animal products, have remained largely free from colonization of domestic 
poultry [71, 72]. Th e spatial and temporal distribution of diff erent S. Enteritidis phage types 
varies between the continents and multiple clones of S. Enteritidis emerged simultaneously in 
geographically separate countries during this pandemic. Diff erent phage types (PT) dominate in 
diff erent continents. For example, PT8, PT13a and PT13 are most common in North America 
[73, 74], while PT4 has been the dominant phage type in the Western Europe and Japan [69, 
75-77] and PT1 in Baltic countries, Poland and Russia [78, 79]. Furthermore, PT14b represents 
a recently emerging phage type in Southern European countries [80]. Th e strains of S. Enteritidis 
have remained more susceptible to antimicrobials than some other Salmonella serovars e.g 
Typhimurium [81].
2.2.2.2  Epidemiology of certain mul? resistant S.Typhimurium strains
A much higher rate of resistance has been reported among the strains of S. Typhimurium than 
among those of S. Enteritidis. For example, a multiresistant S. Typhimurium defi nitive phage 
types (DTs) DT193 in the 70s [82] and DT104 in the late 80s which originated from cattle in the 
United Kingdom emerged as a global health problem and have since then  become common in 
other animal species such as poultry, pigs and sheep [83]. Th e multiresistant DT104 strains are 
generally resistant to fi ve diff erent drugs: ampicillin (A), chloramphenicol (C), streptomycin (S), 
7sulfonamide (Su) and tetracycline (T), referred as resistance type ACSSuT [84]. Genes associated 
with ACSSuT resistance are located in a chromosomal Salmonella genomic island 1 (SGI-1) 
[84, 85]. In addition to DT104, a multiresistant monophasic S. Typhimurium (with antigenic 
structure 4,[5],12:i:-) was rarely identifi ed before the mid-1990s but has now been recognized 
as an emerging pathogen in the EU. Two major clonal lines of monophasic S. Typhimurium 
have emerged in the EU: so-called European and Spanish clones. Th e European clone, which 
has emerged since 2000, harbors a chromosomal region responsible for resistance against at least 
four antimicrobials referred as R-type ASSuT [39, 86, 87]. Th e Spanish clone, fi rst reported in 
Spain in the late 1990s, harbors plasmid-mediated resistance against up to seven antimicrobials: 
ampicillin (A), chloramphenicol (C), streptomycin (S), sulfonamide (Su), tetracycline (T), 
trimethoprim (Tp) and gentamicin (G) [88]. Both of these clones are believed to have evolved 
from a traditional biphasic S. Typhimurium and lack the second-phase fl agellin-encoding 
gene or the ability to express it resulting in a monophasic variant [89]. Th e majority of the 
monophasic S. Typhimurium strains in the European clone belong to the phage types DT193 or 
DT120 [86, 90, 91] while the Spanish clone consists of strains belonging mostly to the phage type 
U302 [92]. In Finland, a signifi cant increase of cefotaxime nonsusceptibility has been registered 
among the strains of monophasic S. Typhimurium isolated from patients with travel history 
to Asia as well [93]. Th e exact reasons for successful colonization of these multidrug resistant 
strains are unknown. However, several factors such as improved mechanism to survive in the 
host or acquisition of bacteriophages encoding antimicrobial resistance to additional drugs and 
virulence factors needed for the fi tness might have had an impact [94].
2.2.3  Human Salmonella infec? ons in Finland
In Finland, the average annual incidence for all reported salmonellosis cases was 44-59 cases 
per 100,000 inhabitants during 2000-2013, including 6-7.5 cases per 100,000 inhabitants of 
domestically acquired infections (statistics of THL). Th e overall occurrence was highest among 
20-29 year-olds and lowest among over 75 year-olds individuals. With a total of 1,952-3,129 
reported cases in 2007-2013, human salmonellosis was the second most common bacterial 
human intestinal disease (aft er Campylobacter) reported in Finland (Fig. 2). Since 2011, the 
overall trend of Salmonella infections has been decreasing in Finland (Fig. 3). Th is decline can be 
most clearly observed among the S. Enteritidis infections that have been acquired abroad.
During 2000-2013, more than 200 diff erent serovars caused salmonellosis in Finland (statistics 
of THL). Of them, 136 were linked to domestically acquired infections. Of all strains, the most 
common serovars were Enteritidis and Typhimurium. In 2014, the most common serovars 
associated with domestically acquired infections were Typhimurium, Enteritidis, monophasic 
S. Typhimurium, Infantis and Newport. Among S. Typhimurium, phage type DT1 has 
been the most common DT since the 1960s. In addition to human infections, DT1 has been 
detected among domestic production animals (cattle, pigs and turkeys) and it has come to be 
considered endemic to Finland [95]. However, in the past years the incidence of monophasic S. 
Typhimurium (antigenic structure 4,[5],12:i:-), has increased. In 2013, the number of infections 
caused by domestic monophasic S. Typhimurium was as high as domestic DT1. In general, the 
majority of domestic monophasic S. Typhimurium are of resistance type ASSuT while domestic 
DT1 strains are fully susceptible to tested antimicrobials. 
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Figure 2: Trends of common enteric bacteria in Finland (2007-2013), data from the National Infectious 
Disease Register (NIDR), THL. 
Figure 3: Th e trend of salmonellosis in Finland (statistics of THL, 2000-2013).
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2.2.4  Infec? ous dose, disease and treatment of Salmonella
How large a dose of Salmonella is necessary for infection depends on host resistance, food 
composition [96] and the virulence and physiological state of the ingested bacterium. Th erefore, 
the infectious dose for salmonellosis is variable. It is thought to be typically between 106-108 
colony forming units for humans. However, infective doses as low as 10 cells have been reported 
[97, 98]. Children, elderly or immune compromised people and pregnant women are more 
susceptible to developing salmonellosis than healthy adults [97, 98].
Human Salmonella infections can lead to four clinical conditions: (1) enteric (typhoid) fever, (2) 
acute gastroenteritis, (3) invasive infections and (4) asymptomatic fecal excretion [99]. Enteric 
fever is a serious disease which occurs only in humans and is due to S. Typhi or S. Paratyphi. 
Commercial vaccines against S. Typhi are currently available [100]. Acute gastroenteritis is the 
most common manifestation of non-typhoid Salmonella infection. Nearly all S. enterica subsp. 
enterica serovars can cause human gastroenteritis but the most of the human infections are 
limited to only a few serovars. Th e incubation time may vary from 4 to 72 hours, with an average 
of 12-36 hours, aft er the ingestion of contaminated food or water. Symptoms are acute onset 
of fever, chills, nausea, occasionally vomiting, abdominal cramping and diarrhea [8]. Th e fever 
usually ends within 72 hours and the diarrhea is usually self-limiting, lasting 3-7 days, although 
some patients have symptoms for as long as 14 days [101]. Th erapy should be directed at 
preventing dehydration. However, the usage of antimicrobial therapy is justifi ed in patients with 
bacteremia, infants aged <3 months and in immunocompromised patients [8]. Th e mortality of 
salmonellosis is low, and less than 1% of reported salmonellosis cases have been fatal [60, 102]. 
In Finland, reactive arthritis occurs in 4.4%-12% of patients aft er Salmonella infection [103-105]. 
Th is sequela most commonly aff ects young adults, and more frequently the white population, 
possibly due to the higher frequency of the HLA-B27 tissue allele in this ethnic group [106]. 
Th ere are probably as many asymptomatic infections as symptomatic, but the real number of 
these remains unknown. People continue to excrete Salmonella bacteria for 3-4 weeks aft er either 
symptomatic or asymptomatic infection [107]. Th e carrier state can be prolonged for up to one 
year. Children may excrete Salmonella for even longer than adults [108]. Furthermore, vaccines 
against two out of 2,600 Salmonella serovars (Enteritidis and Typhimurium) do exist which are 
eff ective in poultry but not in humans or other animal reservoirs such as cattle or pigs [109]. 
2.2.5  Pathogenesis of Salmonella and the main virulence factors 
In order to cause disease, ingested Salmonella cells fi rst need to overcome several non-specifi c 
barriers such as bactericidal action of lactoperoxidases, the pH of the stomach and intestinal 
mucoid secretion and peristalsis. Secondly, they need to overcome host-specifi c defense 
mechanisms which include antibacterial actions of phagocytic cells coupled with the immune 
response. To cause a disease, Salmonella possess numerous virulence factors. Th e majority of 
the genes encoding these factors are located in fi ve highly conserved salmonella pathogenicity 
islands (SPI-1-5) in the chromosome, while others are found in a virulence plasmid (pSLT).
 
In general, it is a characteristic of non-typhoid Salmonella that they are able to colonize 
the gut. Th e attachment of the bacterium to the host’s epithelial receptors is mediated by 
lipopolysaccharide (LPS), fl agellin and fi mbriae and by other large adhesins or autotransporter 
proteins encoded within SPI-3 and SPI-4 [110-112]. Salmonellae can enter host cells by invasion 
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or phagocytosis [113]. Invasion proteins and the invasion locus (inv) in SPI-1 play an important 
role in the invasion [114, 115]. Salmonella invade and survive in macrophages leading to 
infl ammation of the intestines and to gastroenteritis. Th e survival of the Salmonella inside the 
macrophage is supported by factors encoded within, SPI3, SPI-2 and pSLT plasmid [113]. Th e 
virulence of Salmonella is dependent on many virulence determinants. It has been estimated that 
about 4% of the Salmonella genome (which encode over 200 virulence genes) is required for fatal 
infection in mice [116]. Th e need for so many virulence factors could refl ect the complexity of 
Salmonella pathogenesis. 
Lipopolysaccharide and capsular polysaccharide 
Th e serovar-spesifi c lipopolysaccharide chains (LPS) play an important role in inhibiting the 
potentially lytic attack of the host complement system as they hinder the insertion of certain 
complement factors into the inner cytoplasmic membrane which would otherwise initiate 
bacteriolysis [117]. Th us, the short LPS on rough variants are considered less virulent [117]. Th e 
capsular polysaccharide Vi (virulence) antigen have been detected in most strains of S. Typhi, in 
some strains of S. Paratyphi C and seldom in S. Dublin [118-120]. Th e Vi locus is encoded in the 
SPI-7 that is not present in non-typhoid Salmonella serovars [119]. 
Flagella and fi mbriae
Flagella contribute to virulence through the mobility of the organism within its environment, 
allowing it to move towards attractants and away from repellents (chemotaxis), and by aiding in 
adhesion to and invasion of host surfaces [121]. Th e fl agellar fi laments are surface appendages of 
Salmonella and are composed of approximately 20,000 subunits of a unique protein, known as 
fl agellin [122]. To date, 13 diff erent fi mbrial loci have been identifi ed among Salmonellae [123], 
many of which are required for biofi lm formation (e.g. curli fi mbriae and plasmid-encoded 
fi mbriae Pef) [124], attachment to host cells (e.g. type I fi mbriae, curli fi mbriae, Pef, long polar 
fi mbriae Lpf and Std) [125-127], intestinal fl uid accumulation (e.g. curli fi mbriae and Pef) [125] 
and intestinal persistence in mice [128]. 
Salmonella pathogenicity islands (SPI-1 to 5)
SPI-1 and SPI-2 are the best-characterized of the fi ve SPIs. SPI-1 is about 40 kb in size and 
contains at least 29 genes which encode several components of type III secretion system (T3SS) or 
its regulators and its secreted eff ectors enabling Salmonella to effi  ciently penetrate the intestinal 
epithelium [129]. In addition, several chaperons which protect SPI-1 proteins from degradation 
are encoded in SPI-1. SPI-2 contains more than 40 genes including a two-component regulon 
(ssrAB) and a T3SS system which is structurally and functionally distinct from that of SPI-1 
[130, 131].  It is divided in two segments: the smaller part which is involved in tetrathionate 
reduction and the larger part which enable Salmonella to survive and replicate within epithelial 
cells and macrophages [130, 132]. SPI-3 is a 17-kb mosaic structure at the selC tRNA locus 
which encodes proteins with no known functional relationship to each other. Th e genes encoded 
in mgtCB operon, allow Salmonella to transport magnesium at low Mg2+ conditions which is 
required for intramacrophage survival during systemic dissemination [133]. MisL is involved in 
both attachment and long-term persistence [134]. SPI-4 is a 25-kb mosaic structure and contains 
six ORFs, arranged in a single operon siiABCDEF and plays a role during the interactions with 
intestinal epithelium and long-term persistence [111, 135]. Th ese genes may encode a type I 
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secretion system [135]. In addition, it has been speculated that SPI-4 is involved in the secretion 
of a cytotoxin when Salmonella induces apoptosis of infected macrophages [136], however, the 
main function of SPI-4 remains to be determined. SPI-5 is involved in accomplishing several 
pathogenic processes during infection. Th e SigDE operon encodes SigD (SopB), an eff ector 
involved in fl uid secretion in intestinal mucosa and SigE (PipC), its presumed chaperone [137, 
138]. Th e genes pipB and pipA are presumed to contribute to systemic infection in mice [139].
pSLT plasmid
Some Salmonella serovars of clinical importance harbor a serovar-specifi c virulence plasmid 
which varies in size: 95 kb for serovar Typhimurium, 60 kb for Enteritidis, 80 kb for Dublin 
[140]. Th ey all contain a highly conserved 8-kb region of fi ve genes, the spvRABCD locus. Th e 
SpvR is a transcriptional activator, and induces spvABCD expression in the stationary phase in 
response to nutrient limitation. Two genes, spvB and spvC, encode factors for plasmid-mediated 
virulence of serovar Typhimurium [141, 142]. Furthermore, the pSLT plasmid also contains a 
fi mbrial operon (pef) that encodes an adhesion involved in colonization of the small intestine 
[143]. It is noteworthy that highly infectious S. Typhi lacks this virulence plasmid [144].
2.3  Nomenclature, classi? ca? on and general characteris? cs of E. 
coli
Th e history of the Escherichia coli species dates back to 1885, when it was fi rst isolated from the 
feces of a healthy infant [145]. In 1919, the commensal E. coli, was named in honor of its discoverer 
a German paediatrician Dr. T. Escherich. E. coli species belong to the same proteobacterial family 
as Salmonella, Shigella, Yersinia and others, the family of Enterobacteriaceae (Fig. 1). E. coli are 
facultative anaerobic, Gram-negative, rendered motile by peritrichous fl agella, or non-motile, 
lactose fermenting rod-shaped bacteria which are about 2-6 x 1-1,5 μm in size [146].
Based on the clinical pathogenesis, E. coli is classifi ed into 3 major groups: (1) commensal 
E. coli, (2) diarrheagenic E. coli (DEC) and (3) extra-intestinal pathogenic E. coli (ExPEC). 
Commensal E. coli is considered benefi cial for maintaining a healthy intestinal ecosystem. Th ey 
usually colonize the gastrointestinal tract in a few hours aft er birth, becoming a part of the 
normal fl ora and co-existing in symbiosis with the host [4]. However, some E. coli strains have 
acquired specifi c virulence factors, oft en encoded by mobile genetic elements, which allow them 
to adapt into new niches and cause a wide spectrum of diseases. DEC isolates are categorized 
into six specifi c pathogroups based on virulence properties, mechanisms of pathogenicity and 
clinical syndromes (Table 3). Th e major pathogroups within DEC are enteropathogenic E. coli 
(EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. 
coli (EIEC), enteroaggregative E. coli (EAEC) and diff usely adherent E. coli (DAEC) [147, 148]. 
Shigella species should be classifi ed within the species EIEC [149]. However, due to the clinical 
signifi cance of Shigella the traditional nomenclature is still maintained [4]. ExPEC strains cause 
urinary tract infections (by uropathogenic E. coli, UPEC), neonatal bacterial meningitis (by 
meningitis-associated E. coli, MAEC) and sepsis. Th e pathogroup specifi c E. coli nomenclature 
and classifi cation is summarized in Table 3. In addition, the unique mosaic O104:H4 strain that 
caused a large fenugreek-related outbreak in Germany 2011 might represent a new pathogroup 
designated as enteroaggregative-heamorrhagic E. coli (EAHEC) [150]. 
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Th e enterohaemorrhagic E. coli (EHEC) was fi rst described in Canada in the late 1970s [151]. 
During an extensive outbreak associated with a consumption of poorly cooked minced meat 
in the USA in 1982, it was fi rst demonstrated that Shiga toxins produced by EHEC are linked 
to bloody diarrhea [152, 153]. In the same year, it was discovered that a post-diarrheal disease, 
hemolytic-uremic syndrome (HUS), could be caused by EHEC O157:H7 [154]. Most strains 
of EHEC possess some biochemical and physiological characteristics which are uncommon to 
other E. coli including the production of Shiga toxins, inability to ferment sorbitol within 24 
hours, inability to produce β-glucuronidase, carrying of an attaching and eff acing (eae) gene 
and the inability to grow well at temperature >45°C [4]. Th e EHEC strains can be further 
characterized by serotyping which is based on diff erences in antigenic structure on the bacterial 
surface: O-antigen, H-antigen, and sometimes also K-antigen (Kapsel) and F-antigen (Fimbriae). 
Serologically, EHEC bacteria can be divided into two main groups: strains of EHEC O157 and 
non-O157. Of these, most widespread are EHEC O157 strains. Th is might be due to their higher 
virulence. However, over 400 non-O157 serotypes have been associated with human disease 
[155]. Although  EHEC is one of the best-characterized bacterium in clinical microbiology 
laboratories, researchers oft en refer to these pathogens interchangeably as enterohemorrhagic 
E. coli (EHEC), shiga toxin-producing E. coli (STEC), or verotoxin-producing E. coli (VTEC). 
For consistency, in this study all STEC strains are called EHEC and the Stx nomenclature will be 
used.
2.4  EHEC infec? ons in human 
Th e EHEC O157 and non-O157 are zoonotic bacteria. Human infection may be acquired through 
the consumption of contaminated food or water, by direct transmission from person-to-person 
or from colonized animals or fecally-contaminated environments to humans [164]. In contrast to 
infections caused by ETEC and EPEC, EHEC infections are mainly found in developed countries. 
Th e infections are most common among children less than 5 years. Also, severe complications 
such as HUS are more commonly reported in children and the elderly whereas asymptomatic 
carriage is more common in the age groups between. Major EHEC outbreaks have resulted in 
greater public awareness, but sporadic infections cause the largest disease burden as most EHEC 
infections are sporadic. In a recent study, it was shown that about 20% of the infections were 
secondary infections [165].
2.4.1  Sources and risk factors of EHEC infec? ons 
Ruminants, particularly healthy cattle, are a major reservoir for human infections caused by 
sorbitol-negative EHEC O157:H7. Similar to those, sorbitol-positive EHEC O157:H7 and non-
O157 are also oft en associated with cattle and ruminants [166, 167]. In addition to cattle, EHEC 
are detected in a wide spectrum of animals e.g. sheep, goats, deer, moose, swine, horses, dogs, 
cats, pigeons, chickens, turkeys and fl ies [168]. In contrast to humans, most EHEC infections 
of animals are clinically asymptomatic [169]. Identifi ed risk factors for EHEC infection include 
living in or visiting a place with farm animals [170, 171], consumption of undercooked beef and 
consumption of cold sliced meat [172]. In addition, unpasteurized milk, yogurt and cheese made 
of unpasteurized milk are commonly reported as sources of EHEC O157:H7 infections [173-
178]. Furthermore, numerous plant products have been reported as vehicles to human disease, 
including apple cider and vegetables such as lettuce, radishes, alfalfa sprouts and spinach [179-
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182]. Recently, novel vehicles such as cookie dough have been reported [183]. Lake water and 
water from private wells have been associated with human infection as well [184-186].
2.4.2  Occurrence and epidemiology of EHEC infec? ons
Since its discovery in 1982, EHEC has been recognized as an emerging pathogen in 
industrialized countries causing mostly sporadic infections or small family-related clusters, 
although large foodborne outbreaks have also been reported. Th e incidences of EHEC 
infections vary among geographic areas including some high EHEC O157:H7 incidence 
regions such as some regions of Argentina [187, 188], Canada [189], Ireland [190] and 
Scotland [191] (Table 4). Strains of EHEC serotype O157:H7 are the primary cause of bloody 
diarrhea and HUS in many countries. Th ere are currently no exact data available on the 
frequency of EHEC infection in Argentina, but the incidence of EHEC O157-mediated HUS 
is among the highest in the world and HUS is considered endemic in Argentina [187]. Th e 
dominance of EHEC O157:H7 as a cause of illness might be misleading because of a lack 
of detection methods and inconsistent testing frequencies for other non-O157 serotypes. 
Despite these limitations, the incidence of non-O157 as disease agent in human EHEC 
infections has steadily increased worldwide. For example in some EU countries, EHEC non-
O157 are more prevalent over EHEC O157:H7 [192]. 
Table 4: Incidence of EHEC infections in certain regions and the most common EHEC non-O157 
serogroups in the region.
Geographic area/
country
Incidence of EHEC 
(O157 and non-O157)
Major non-O157 serogroups 
associated with human disease
Reference
Australia 0.4 O26, O111 [193]
EU* 1.1-1.9 O26, O91, O103, O104, O111, O113, 
O128, O145, O146
[58, 194]
Finland 0.2-1.8 O26, O103, O145 [195-197]
Sweden 4.9 O26, O103, O121 [58]
Canada 3.0-6.0 O26, O91, O103, O111, O121 [189, 198]
Japan 2.0-3.0 O26, O111, O121, O103, O145 [199, 200]
Argentina 10.4-12.2 O8, O26, O113, O145, O174 [188, 201]
USA 0.9-1.2 O26, O45, O103, O111, O121, O145 [202, 203]
*) Data based on 25 reporting countries from the EU including Finland and Sweden.
 
EHEC has been estimated to cause more than 265,000 illnesses each year in the USA, and more 
than 3,600 hospitalizations and 30 deaths [203]. In 2010, the annual incidence rate of reported 
EHEC infection was 0.9 cases per 100,000 in the USA [204]. Strains of O157:H7 are still the most 
frequently isolated EHEC strains from patients in the USA, although, the number of infections 
caused by non-O157 has been estimated to vary from 30% to 50% [202, 205]. Among non-O157 
infections, the most common O-groups in the USA were O26 (37%), O103 (24%), and O111 
(17%) and about 20% of EHEC O157 infections were associated with recognized outbreaks [204]. 
Similar incidence values as in the USA have also been reported in the EU, although regional 
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variations within the continents do occur. Nevertheless, the EHEC incidence remains in the USA 
and in the EU over 2-fold higher than the annual incidence in, for example, Australia (0.4 cases 
per 100,000 population) [193]. In the EU, an increasing trend of confi rmed EHEC cases in 2008-
2011 has been reported. During that time an annual incidence rate in the EU has varied between 
0.96-1.15 per 100,000 inhabitants, except in 2011 when 2.5 cases per 100,000 inhabitants were 
reported. Th e increase in 2011 was due to a large outbreak caused by an enteroaggregative Shiga 
toxin-producing E. coli O104:H4 in Germany that resulted in 3,842 infected people [206]. When 
excluding Germany, the highest EHEC notifi cation rates in 2011 among European countries 
were observed in Ireland, the Netherlands and Sweden. Th e prevalence of non-O157 serotypes 
has been higher than those of O157 in some European countries. For example, 82% in Germany 
[192, 207], 80% in the Netherlands [208] and 74% in Denmark [209] of the infections have 
been caused by non-O157 serotypes. Furthermore, EHEC non-O157 has been associated with 
10-30% of reported HUS cases in Germany, Italy and UK [210]. EHEC of serotype O26:H11/
H− has emerged as the most common non-O157 EHEC strain in human diseases in the EU [207, 
211-214] and the United States [202, 215]. It has also been increasingly isolated from patients 
in South America [187], Asia [216], and Australia [217]. Another feature among the European 
EHEC strains is the ability of some EHEC O157 strains to ferment sorbitol. Th ese sorbitol-
positive EHEC O157 strains oft en express a non-motile phenotype (H−), althougt H7 gene is 
applifi ed in the PCR analysis. Th ese strains have caused several outbreaks in the EU but they have 
seldom been reported from other continents [166, 218]. Th us, rare serotypes with new virulence 
properties, as experienced with the German outbreak of EAHEC O104:H4, is worthy of note. 
As with Salmonella, a seasonal variation has been noted throughout the world with a tendency 
of EHEC infections to occur in the late summer during the warm months [219]. Th e reasons 
for this phenomenon are not known, however it has been speculated that it may be related to 
infection trends in animal hosts or to storing food at inappropriate temperatures.
2.4.3  EHEC infec? ons in Finland
Most of the EHEC infections in Finland are sporadic or family-related secondary infections 
[197]. Of all infections, about 70-80% are considered domestically acquired (Fig. 4) but the 
number of infections that were acquired abroad has increased during the previous two years. 
During 1998-2008 the annual incidence of EHEC infections in Finland had been low ranging 
from 0.2 to 0.6 per 100,000 populations [195, 197]. Since 2009 an emerging trend of EHEC 
infections has been observed, and in 2013 a new record was established as almost 100 EHEC 
infections were reported. Th e annual incidence rate rose into 1.8 per 100,000 populations in 2013 
[7]. During 2009-2014, about 70% were domestically acquired infections. Since the beginning of 
the surveillance in 1996, EHEC serotype O157:H7 and it variant O157:H- have every year caused 
the majority of the domestically acquired EHEC infections in Finland. 
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Figure 4: Number of domestic and travel-related EHEC infections 1996-2014 (statistics of THL).
2.4.4  Infec? ous dose, disease and treatment
In contrast to the relatively high infectious dose for Salmonella, the infectious dose of EHEC 
is low:  less than 10 cells have been reported to cause a disease [220]. More than 400 EHEC 
serotypes have been associated with human disease, causing illnesses that range from symptom-
free carriage to bloody diarrhea, HUS and death.  EHEC strains are usually non-invasive and 
HUS is rarely complicated by bacteraemia, but some serotypes invade into the bloodstream [221]. 
Aft er a mean incubation period of 3 days (can vary from 1 to 8 days) infected individuals develop 
watery diarrhea, vomiting (30-60% of cases) and abdominal pain with cramps. About 30% of 
patients have mild fever, usually observed in the early stages of the disease [191]. About 1-3 days 
aft er onset, over 70% of the patients develop bloody diarrhea though lower frequencies have also 
been reported. Th e bloody diarrhea is more common in infections caused by EHEC O157:H7 
[191]. Most patients (95%) recover spontaneously within a week of onset, whereas some of the 
patients progress to HUS or other complications. Th e proportion of patients who progress to 
severe bloody diarrhea and/or HUS varies for diff erent strains of EHEC, as well as by the age and 
immunological status of the infected patient [222]. In sporadic cases, 3-7% of cases progress into 
HUS [219] while in specifi c outbreaks a HUS incidence of up to 20% has been reported [223]. 
HUS occurs 5-13 days aft er the onset of diarrhea and is characterized by hemolytic anemia with 
fragmented erythrocytes, thrombocytopenia and acute renal failure [224]. HUS mortality has 
been reported to be 3-5% [224]. Although HUS caused by serotype O157:H7 has been associated 
with the highest mortality, serotypes O26:H11 and O145:H28 can lead to fatal HUS as well [207]. 
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To support this, recent studies have indicated that there is no statistically signifi cant diff erences 
in the Stx proteins encoded by  EHEC O157 and non-O157 strains or in their level of toxicity 
[225] and there appears to be no signifi cant diff erence in the long-term outcome of HUS caused 
by non-O157 EHEC and EHEC O157 [226]. Th us, it is possible that factors other than Stx may 
contribute to chances of developing HUS [227].
Th e current treatment for  EHEC  infection is supportive and the infected patients should be 
monitored for dehydration, anuria and other symptoms that might suggest HUS [228]. Drugs 
commonly used in the hospital to treat bacterial enteric infections such as antibiotics, anti-
motility agents, anti-infl ammatory medicines should be avoided for treatment of EHEC-infected 
patients [222, 229].  
2.4.5  Pathogenesis of EHEC
Aft er ingestion, EHEC adheres to and primarily colonizes the large intestine and forms attaching 
and eff acing (A/E) lesions on the mucosal epithelium [230]. A/E lesions are characterized by loss 
of the epithelial micro-villi, intimate attachment of the bacteria to the cell, and accumulation of 
polymerized actin fi laments in high concentrations and a formation of a pedestal-like structure 
in the epithelium [147]. All the proteins needed for the formation of A/E lesions are encoded by 
a chromosomal pathogenicity island known as the locus for enterocyte eff acement (LEE) [231]. 
In contrast to some Salmonella serovars, Shigella species and EPEC, EHEC bacteria are generally 
unable to invade the HEp-2 cell lines and thus, are considered usually non-invasive [232]. Th e 
released Stx toxins bind to their target receptor, a glycolipid receptor globotriaosylceramide 
(Gb3), and leading to an increase in proinfl ammatory cytokines from host cells and to irreversible 
inhibition of protein synthesis [233]. Th e intestinal vascular injury leads to necrosis and intestinal 
perforation that, together with the infl ammatory response, cause the bloody diarrhea [222]. 
Stx toxins can also be absorbed across the gut epithelium into the bloodstream by a process of 
receptor-mediated endocytosis where they bind to polymorphonuclear leukocytes [234]. At 
target organs such as kidney and brain, Stx toxins bind to Gb3 receptors. For example, renal 
glomerular endothelium expresses high levels of Gb3 in humans, and Shiga toxin production 
results in acute renal failure, thrombocytopenia, and microangiopathic hemolytic anemia, all 
typical characteristic of HUS [154, 235]. In the brain the Stx toxins can cause endothelial damage 
and thrombotic disorders leading to neurological symptoms [236].
2.4.6  Virulence factors of EHEC
Th e primary virulence determinants of EHEC strains are chromosomally encoded. Th ese include 
the Shiga toxin (Stx) and its variants as well as the locus of enterocyte eff acement (LEE) encoding 
A/E lesion [237]. Also, plasmids such as pO157 and pO113 may play an important role in the 
pathogenesis of EHEC [238].  In addition, new putative virulence factors could be detected via 
next-generation sequencing methods in the future.
2.4.6.1 Main virulence factors in chromosome
Shiga toxins (Stx) and stx variants
Th e defi ning characteristic of EHEC is the production of Shiga toxin (Stx) [4]. Th e name Shiga 
toxin originates from the DNA sequence homology with the Stx of Shigella dysenteriae [239]. 
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Shiga toxins belong to a family of AB5 toxins, characterized by an enzymatically active A 
subunit of about 32 kDa non-covalent linked to a pentamer of fi ve identical receptor-binding 
B subunits each of about 7.7 kDa [147]. Both toxins are encoded by the stx genes located in a 
temperate bacteriophages that are inserted as prophages at specifi c insertion sites into the EHEC 
chromosome [240]. For example, the strains of O157:H7 can carry several distinct phages and 
at least fi ve diff erent insertion sites, of which yehV and wrbA are most commonly occupied 
[241]. Th e pentameric B unit of most Stx variants binds specifi c to the glycolipid receptor 
globotriaosylceramide (Gb3), except that the variants Stx2e and Stx2f prefer to bind to the 
longer globotetraosylceramide (Gb4) [239]. Two major groups, Stx1 and Stx2, showing about 
60% nucleotide sequence identity with each other, have been detected [242]. Moreover, these 
two toxin groups can be further divided into several variants. Th e nomenclature is not conclusive 
and new variants of Stx are described. Th e Stx1 has three variants Stx1a, Stx1c, and Stx1d. Th e 
Stx2 group is more heterogeneous and can be divided into seven variant: Stx2a, Stx2b, Stx2c, 
Stx2d, Stx2e, Stx2f, Stx2g [162, 243]. In addition, a strain can produce either Stx1 or Stx2 or both 
toxins [242]. Generally, Stx2 has been more frequently associated to severe disease and HUS 
than Stx1 [243, 244]. Several studies have shown that  stx gene variants stx2 and  stx2c are more 
oft en associated with HUS [163, 245, 246], however, strains carrying  the gene stx2d [247, 248] 
and stx2e [243] have also been isolated from humans with HUS.
LEE associated virulence factors
Th e factors responsible for the histological events associated with A/E lesions of EHEC are encoded 
in the LEE pathogenicity island in the chromosome [4]. Th e LEE consists of approximately 
41 genes, divided into fi ve major operons (LEE1-5), that encode for a type 3 secretion system 
(T3SS), regulators, chaperones, and eff ector proteins [231]. Th e fi rst gene encoded in  LEE1, 
regulator (Ler), acts as the major transcription factor of the pathogenicity island, regulating 
expression of the genes in theentire LEE area [249]. In addition, the up regulation of the genes 
on LEE occur through quorum sensing (QS) mechanisms which allows even small number of 
bacteria to form A/E lesions and attach [250]. Th e major feature of T3SS encoded by genes in 
LEE is the translocation of a variety of virulence factors from the bacterium into the host cell 
via a fi lamentous needle complex formed by EspABD (“EPEC-secreted proteins”). Th e EHEC 
translocates its own receptor Tir (transmembrane intimin receptor) which is inserted into the 
host cell’s plasma membrane where it acts as an adhesion receptor for adhesion protein called 
intimin. Intimin is an important bacterial outer membrane protein encoded by the gene eae and 
its variants. Th e Intimin–Tir interaction mediates the attachment [251]. Currently 17 intimin 
subtypes have been described and named aft er the Greek alphabet [252]. Subtypes eae-α, eae-β 
and eae-γ have been commonly isolated from the strains which have caused HUS [252]. A subset 
of Type III eff ector proteins e.g. Map, EspF, EspG, EspH, EspB and SepZ translocate into the host 
cell where they cause a variety of reactions resulting in diarrhea [251]. 
2.4.6.2 Main virulence factors in plasmids
pO157
A large virulence plasmid pO157 is found in almost all clinical O157:H7 strains isolated 
from humans. Th e production of the O157:H7 enterohemolysin is associated with this 
plasmid [253]. Th e pO157 plasmid is about 94 kb in size and contains an EHEC hly operon 
which consists of hlyC, hlyA, hlyB, and hlyD genes and is about 60% homologous with the 
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alpha-hemolysin gene of E. coli [4]. Like alpha-hemolysin, enterohemolysin is able to form 
pores in membranes of erythrocytes and lyse certain eukaryotic cells [253]. In the case 
of enterohemolysin, hemolysis is observed on blood agar aft er overnight incubation, in 
contrast to the rapid 4h hemolysis associated with alpha-hemolysin [254]. Th e exact role of 
enterohemolysin in EHEC pathogenesis is not fully clear. In addition to enterohemolysin, 
the sequence analysis of pO157 has revealed some putative virulence genes [255]. Th ese 
include a catalase-peroxidase (katP) [256], a type II secretion system apparatus (etp) [257], 
a serine protease (espP) [258], a putative adhesin (toxB) [259],  a zinc metalloprotease (stcE) 
[260], and an eae conserved fragment (ecf) [261]. Although sorbitol-positive and sorbitol-
negative EHEC O157/H7/H- strains share several virulence factors, their plasmids diff er 
from each other. Th e plasmid of sorbitol-fermenting EHEC O157 is about 30 kb larger (ca. 
30%) and the major diff erences are the absence of katP, espP, and toxB genes [262].
pO113
STEC auto-agglutinating adhesion (Saa) and STEC autotransporter contributing to biofi lm 
formation (Sab) are both plasmid-encoded adhesins that have been identifi ed primarily in the 
EHEC LEE-negative O113:H21 strains and might contribute to pathogenesis [263, 264]. Several 
variants of the saa gene have been identifi ed and it has been hypothesized that variations at the 
3’ end infl uence the adhesive affi  nity, and that shorter variants are less adhesive than longer 
variants [264].
2.5  Foodborne disease outbreaks caused by Salmonella and EHEC
2.5.1  Certain large outbreaks caused by Salmonella
Over the past fi ve years, the number of outbreaks caused by Salmonella has been decreasing in 
concordance with a steady decrease in reported human salmonellosis cases in the EU and in the 
USA. Th is is largely due to declining egg-related outbreaks [194]. Major outbreaks of foodborne 
salmonellosis in the last decades are of interest because they highlight the diverse range of food 
items and diversity of Salmonella serovars that cause human disease. 
In 2004-2005, a large outbreak caused by S. Bovismorbifi cans associated with consumption 
of raw minced pork was reported in Germany. About 400 persons were infected and one died 
during the outbreak [38]. In 2005, S. Hadar contaminated vacuum-packaged chicken infected 
more than 2,000 in Spain [265]. In 2008, a large multi-state outbreak of S. Saintpaul infections 
associated with contaminated jalapeno peppers occurred in the USA. More than 1,442 people 
were infected and 2 died [266]. One of the largest food recalls in the USA history occurred in 
2009 when S. Typhimurium contaminated peanut butter caused an outbreak where more than 
700 persons fell ill and 9 died [57].
2.5.2  Certain outbreaks caused by Salmonella in Finland
During 2007-2014, a few Salmonella outbreaks have been reported annually in Finland. Most 
of them were small or medium outbreaks and sources are mostly unknown. Th e majority of 
Salmonella outbreaks which have led to outbreak investigations are foodborne. Th e outbreak 
investigations have identifi ed some food vehicles such as iceberg lettuce in 2008, sprouts in 2007 
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and 2009 and frozen pre-cooked chicken cubes in 2012 (Table 5). Among others, the serovars 
Agona, Infantis, Isangi, Mikawasima, Poona, Typhimurium DT1, DT104, DT120, monophasic S. 
Typhimurium U311 and Urbana have been frequently associated with small outbreaks or clusters 
of unknown source in Finland.
Table 5: Selected Salmonella outbreaks with identifi ed vehicle in Finland 2007-2013.
Year Serotype Xbal-PFGE/
MLVA type
No. of 
cases
Other 
countries 
involved
Vehicles Reference
2007 S. Agona SAGO39 12 Sandwich cake Statistics of 
THL
2007 S. Weltevreden SWEL4 7 Norway and 
Denmark
Alfalfa sprouts [267]
2007 Salmonella spp. 14 Contaminated 
drinking water
[267]
2008 S. Newport/ S. 
Reading
SNWP59 and 
SREA4-7
107 Iceberg salad [49]
2009 S. Bovismorbifi cans SBVS4 42 Alfalfa sprouts [269]
2012 S. Enteritidis PT1B SENT117 53 Estonia Frozen chicken 
cubes
Statistics of 
THL
2013 S. Typhimurium 
DT135
STYM243/ 
MLVA 
2-14-11-11-312
8   Cattle farm 
contact
Statistics of 
THL
2.5.3  Certain large outbreaks caused by EHEC
EHEC O157:H7 and non-O157 strains have caused hundreds of outbreaks worldwide and 
the largest have been reported in Canada, Japan, Germany and the United Kingdom. In 
1993, a large outbreak caused by EHEC O157:H7 contaminated ground beef served in a fast-
food restaurant occurred in the USA. More than 700 individuals were infected, 55 had HUS 
and four children died [270]. In 1995, a large Australian community outbreak caused by 
EHEC O111:H- and associated with the consumption of fermented sausages [271] resulted 
in more than 200 people being infected and 22 children had HUS. In 1996, the largest 
outbreak known occurred in Japan, in Sakai City, where about 8,000 persons, mostly school 
children, were infected by EHEC O157:H7 [272]. A total of 106 children had HUS and three 
of them died. White radish sprouts served as a part of a school lunch were identifi ed as 
the vehicle of the EHEC infections. In 1996, Europe experienced a large O157:H7 outbreak 
in Central Scotland where about 500 persons had gastroenteritis aft er consumption of 
meat from a local butcher’s shop and 20 died  [273]. In 2005, meat products from a local 
butcher’s shop in Wales caused the second largest O157:H7 outbreak in the UK where 157 
persons were infected and one died [274]. Th e largest waterborne outbreak occurred in 
2000 in Canada where a drinking water supply became contaminated with EHEC O157:H7. 
As a result, 2,300 persons became ill, 27 patients developed HUS and six died [275]. Th e 
largest non-O157 EHEC outbreak ever occurred in summer 2011 in Germany when with 
a multiresistent EHEC O104:H4 contaminated fenugreek sprouts infected 3,842 persons. A 
total of 2,987 cases of laboratory-confi rmed gastroenteritis with 18 deaths and 855 cases of 
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HUS with 35 deaths were reported [276]. Interestingly, the genome of epidemic O104:H4 
strains harbors a unique combination of genes present in enteroaggretative E. coli (EAEC) 
and in enterohemorrhagic E. coli (EHEC) pathotypes: two mobile elements, a phage carrying 
the stx genes and a plasmid carrying an aggregative adherence fi mbria (AAF) operon and 
aggR gene, contribute to the main virulence of this hybrid strain [276, 277]. However, in 
contrast to regular EAEC and EHEC,  the epidemic strains lack the EAEC-specifi c plasmid 
carrying AAF/III and astA encoding for the EAEC heat-stable enterotoxin (EAST1) and the 
EHEC-specifi c plasmid carrying the gene for enterohemolysin (hlyA) and LEE (locus for 
enterocyte eff acement) pathogenity island [150]. 
2.5.4  Certain outbreaks caused by EHEC in Finland
In 1996, an enhanced microbiological surveillance of EHEC infections was initiated in Finland. 
During the surveillance between 1996-2014, three outbreaks caused by EHEC with known 
sources or vehicles were detected (Table 6). Th e fi rst domestic outbreak caused by sorbitol-
negative EHEC O157:H7:PT2:stx2:eae:hlyA in 1997 was associated with swimming in a lake 
[185]. During this outbreak, 18 individuals were infected and two children died. Since then, 
two foodborne outbreaks in 2001 and in 2012 have been reported in Finland. In 2001, sorbitol-
negative EHEC O157:H7:PT14:stx1:stx2:eae:hlyA -contaminated imported minced meat used 
in kebab was verifi ed as source of a small outbreak (statistics of THL). Th e 2012 outbreak was 
caused by sorbitol-positive EHEC O157:H-:PT88:stx2:eae:hlyA which was transmitted through 
unpasteurized milk and animal contact [278]. Several potential clusters or outbreaks have been 
identifi ed but sources have remained unknown or microbiologically unverifi ed.
Table 6: EHEC outbreaks with identifi ed vehicle in Finland 1997-2014.
Year Serotype Phage 
type
Vehicle Reference
1997 O157:H7 2 Swimming water [185]
2001 O157:H7 14 Kebab meat Statistics of 
THL
2012 O157:H- 88 Unpasteurised milk [278]
2.6  Epidemiological typing of Salmonella and EHEC 
Multiple bacterial typing methods are used to diff erentiate bacterial strains of the same species. 
Phenotyping methods are those that detect characteristics expressed by the microorganism 
and genotyping methods are those that involve direct DNA-based analysis of chromosomal 
or extra-chromosomal genetic elements. Both are essential epidemiological tools but the 
recent development of molecular methods has especially provided new tools for surveillance, 
outbreak detection and infection prevention and control. Th e choice of a molecular method or 
combination of methods depends on bacterial species, reason for typing as well as time and the 
resources of the laboratory. 
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2.6.1  Phenotyping methods
Serotyping
Serotyping is probably the most important phenotyping method in the world and it has been 
standardized to a level which allows the results to be compared internationally. Serovars of 
Salmonella are defi ned based on the antigenic structure of O (somatic) antigens of the cell surface 
and H1 and H2 (fl agellar) antigens of the phase 1 or phase 2 and sometimes the Vi (capsular) 
antigens which, however, are present in very few serovars, for example in S. Typhi. Th e antigens 
are detected using glass slide agglutination with usually commercially produced antisera. Th e 
Salmonella serovar result is interpreted from the specifi c pattern of agglutination reactions using 
the White-Kauff mann-Le Minor classifi cation scheme [13, 18]. In 2015, more than 2,600 serovars 
of Salmonella have been identifi ed. Th e serotyping of EHEC strains is also based on diff erences in 
antigenic structure on the bacterial surface which include O-antigen, H-antigen, and sometimes 
also capsular K-antigen and F-antigen (fi mbriae). In 2015, over 400 O:H-types of EHEC have 
been reported  [155]. A minority of Salmonella or EHEC strains remain O-nontypeable and are 
referred to as “O rough”.  Some strain cannot be H-typed, because they are non-motile. However, 
most of Salmonella and EHEC strains with non-motile phenotype can be H-typed by PCR or 
sequencing [279]. 
Traditional serotyping (under standardized conditions) has proven to be a robust and 
reproducible method. Th e advantages of serotyping include good discriminatory power and 
epidemiological concordance. However, slide agglutination is time-consuming and takes at least 
3 days for Salmonella and up to one week for EHEC O:H-typing. Furthermore, expensive antisera 
of good quality are required and some strains are not typeable. Th e major disadvantage of 
serotyping is that although it provides a good discriminatory power, the typing does not provide 
any information on the relatedness between the diff erent serotypes. In general, the serotype is, 
however, oft en the fi rst sign of an ongoing outbreak and is mostly used in conjunction with other 
subtyping method or methods. 
In addition to traditional serotyping, the serotyping of the most common Salmonella serovars 
and EHEC O-groups may be performed using conventional or real-time PCR techniques [280, 
281]. Other molecular subtyping approaches available in the reference laboratories, such as 
pulsed-fi eld gel electrophoresis PFGE [282] or multilocus sequence typing MLST [283] have also 
been suggested for Salmonella typing at the serovar level. Furthermore, some commercial kits 
based on DNA microarray technology (Check&Trace Salmonella, Check-Points PV) or based 
on microsphere suspension array technology (Luminex xMAP®, Salmonella serotyping assay, 
Luminex Corporation) are available for determination of common Salmonella serovars [284].
Phage typing
In addition to serotyping, certain bacterial strains can be phenotypically further subtyped 
by phage typing.  Phage types are determined by resistance or sensitivity of the strains to a 
standardized set of typing phages and the lytic pattern obtained allows assignment to a specifi c 
phage type. Th e strains exhibiting a lytic pattern that does not correspond to a known phage type 
are designated as “reacts but does not confi rm” (RDNC) and strains that did not react with any of 
the typing phages are “not typeable” (NT). Phage typing is performed commonly for Salmonella 
serovars Typhimurium using 36 diff erent phages [285] and Enteritidis using 17 diff erent phages 
Review of the Literature
23
[286]. So far, more than 300 defi nitive phage types (DTs) for S. Typhimurium and more than 
60 for S. Enteritidis have been recognized [287]. In 1987, a standardized phage typing schema 
with 16 phages for EHEC O157 was developed and so far, more than 80 phage types have been 
recognized [288]. 
Phage typing has proven to be an important tool for strain characterization. It is cheap and does 
not require specifi c equipment and the results obtained have been applied since the mid-60s in 
surveillance, source attribution and outbreak investigations [45, 289]. Th e limitations of phage 
typing include occurrence of non-typeable strains and inadequate discriminatory power. Further 
drawbacks are that it is performed only in some of the National reference laboratories (since only 
these institutions have access to the defi ned sets of typing phages) and the interpretation of the 
lysis results requires considerable experience [290]. For example, some international outbreaks 
have been confused due to diff erent phage type interpretation between countries [289]. Also, a 
phage-conversion event due to, for example, expression of temperate phages or loss or gain of a 
plasmid might lead to diff erent interpretation of a certain phage type [291]. In order to guarantee 
the comparability among the laboratories and maintain the expertise, standardization and annual 
external quality assurance are important for the Reference laboratories. Despite the limitations, 
phage typing still is a valuable tool for the fi rst evaluation of potential outbreak, especially for less 
common phage types, or identifying strains related to certain countries or sources [292, 293].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing is an important and useful test performed by the clinical 
microbiology laboratory enabling an optimal antimicrobial treatment of the patient if needed. 
Th e method is also commonly used for surveillance of resistance among bacteria and for strain 
typing of Salmonella and EHEC. Resistance profi les towards a specifi c set of antimicrobials can 
be determined by the disk diff usion method into three categories: susceptible (S), intermediate 
(I) and resistant (R). In order to harmonize the performance and determination of breakpoints 
for each drug, standardized protocols have been developed by the Clinical Laboratory 
Standard Institute (CLSI) and the European Committee on Antimicrobial Susceptibility 
Testing (EUCAST). Th e method is cheap, simple and does not require specifi c equipment. Th e 
drawbacks include poor discriminatory power and instability of certain resistance factors under 
selective pressure or storage that are carried in mobile elements such as plasmids and integrons 
[294]. Furthermore, there is a lack of harmonization in terms of drugs tested and criteria used 
for interpretation, particularly between human and veterinary laboratories [295]. 
Other phenotyping methods
Phenotype MicroArrayTM (PM) technology (by Biolog, CA, USA) is based on simultaneous 
testing of large amounts of bacterial growth phenotypes [296, 297]. Preconfi gured 96-well plates 
can be used for testing the ability to utilize carbon, nitrogen, phosphorous and sulfur substrates, 
the cellular response to diff erent pH conditions, osmolytes and chemicals such as antibiotics. 
PM assay measures cellular respiration colorimetrically via reduction of a tetrazolium dye. 
Metabolized substrates generate a purple color whose intensity is monitored and recorded 
automatically with a camera on the Omnilog instrument [297]. Th e PM technology can be 
applied for an overview of metabolic capability or it can be tailored to address specifi c research 
needs, also related to outbreaks. For example, PM analysis of the EHEC O157:H7 strain related 
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to a spinach outbreak in the USA showed a rare N-acetyl-d-galactosamine-negative phenotype, 
which had only been found once before [298]. However, for routine surveillance of foodborne 
pathogens, it is too expensive and it would be challenging to cluster metabolic diff erences in the 
outbreak situation.
2.6.2  Genotyping methods
Phenotypic typing methods, which require time, skilled personnel and expensive sera, have led to 
the development of typing methods based on genotypic information. Currently used molecular 
typing methods include techniques such as nucleic acid amplifi cation (polymerase chain reaction, 
PCR and multilocus variable-number tandem repeat analysis, MLVA), restriction endonuclease 
digestion (pulsed-fi eld gel electrophoresis, PFGE) and nucleotide sequencing techniques (single 
gene sequencing, multilocus sequence typing, MLST and whole genome sequencing, WGS).
Polymerase chain reaction (PCR)
PCR was developed by Saiki et al., in 1985 and Mullis and Faloona in 1987 [299, 300]. In PCR, a 
known DNA sequence is amplifi ed from the genome using specifi c primer pairs which hybridize 
to the complementary target sequence and thermostable DNA polymerase which catalyzes 
the assembling of nucleotides. All newly synthesized PCR-product are used as templates in 
the following cycle. One PCR cycle consists of three thermal steps: denaturing of the double 
strand DNA, annealing of the primers to each single strand and elongation of the fragment. 
In theory, PCR can multiply the amount of DNA molecules exponentially up to a billion-fold. 
Th e advantages of PCR include sensitivity and portability. However, the sensitivity is also the 
disadvantage of PCR since contaminating DNA is also amplifi ed.
PCR methods (conventional, real-time and multiplex) have been widely used for both pathogen 
identifi cation from diff erent sample types and for detection of virulence genes for typing purpose. 
PCR has been applied for detection of stx genes which are characteristic of both EHEC O157 and 
non-O157 and for invA gene which is characteristic of Salmonella [301]. In addition, further 
PCR-based characterization of stx genes into diff erent variants has improved the epidemiological 
investigations while certain variants have been associated with more severe disease [302]. PCR-
based methods have also been used for the determination of the most common EHEC [281] and 
some Salmonella serovars [280, 303, 304]. Moreover, PCR methods for virulence gene profi ling of 
EHEC by 5-plex PCR [279, 305] or rapid detection of diff erent pathogroups of E. coli by 16-plex 
PCR [306] have been successfully developed. PCR assays specifi c for EAHEC O104:H4, which 
was associated with the large outbreak in Germany, have recently been developed [307].
Pulsed- fi eld gel electrophoresis (PFGE)
PFGE was initially been developed in 1984 [308]. In the last decade, it has become the primary 
typing tool used in identifi cation of bacterial relatedness and in outbreak investigations 
[309]. Th ere is a long tradition aiming at international harmonization of PFGE protocols for 
diff erent foodborne pathogens by PulseNet [310]. Th erefore, PFGE is considered as “the gold 
standard” among bacterial molecular typing [311, 312]. PFGE is a molecular typing method in 
which the whole genome of the bacteria is fragmented using rare cutting restriction enzymes 
(endonuclease). Th ese enzymes recognize certain restriction sites in the genome usually yielding 
less than 30 fragments. For Salmonella and EHEC, the restriction enzyme XbaI has been the most 
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used. Th e resulting fragments, which are mostly large, are then run in an agarose gel within an 
electric fi eld in which the angle is changed periodically, in order to allow the large fragments to 
move through the gel. Even fragments of up to 10 Mb can be separated by PFGE. Th e fragments 
move through the gel according to size and create a “fi ngerprint” based on the position of the 
bands that defi nes the type. Commercially available soft ware programs such as Bionumerics 
(AppliedMaths, Kortrijk, Belgium) are available for accurate analysis and PFGE patterns can be 
shared for global comparison [313].
Th e advantages of PFGE include high discriminatory power and epidemiological concordance. 
Numerous studies have demonstrated its value in outbreak investigations of Salmonella and 
EHEC [314-316]. Moreover, it has high typeability since almost all strains can be typed. Th e 
most widely used standardized PFGE protocol is the PulseNet protocol developed for long-term 
surveillance and outbreak investigation of Salmonella and EHEC infections [310]. In addition, 
international PFGE databases such as PulseNet have been established which allow the rapid 
detection of the spread of new subtypes [315, 317, 318]. Although widely used, PFGE has several 
limitations. For example, the method is labor-intensive taking at least 2-3 days (in addition to 
sample preparation), cannot be automated, is expensive and requires skilled personal to analyze 
the gels [319]. Another drawback is the lack of clear rules about how to interpret PFGE data 
in outbreak situations or how to cluster outbreak-related strains. For example, two outbreak-
related strains may show minor diff erences in their PFGE pattern [316] whilst identical PFGE 
profi les may be generated to outbreak-unrelated strains of common clones such as S. Enteritis 
PT4 [320] or S. Typhimurium DT104 [321]. Th e diff erences in the PFGE profi le of outbreak-
related strains are thought to be due to point mutations, inserts and deletions in the genome 
or loss or acquisition of a plasmid. According to the generally accepted “Tenover criteria” a 
single point mutation in a restriction site may result in a diff erence of up to three bands and 
therefore profi les diff ering from each other by one to three band positions should be considered 
closely related [312]. More recent guidelines for foodborne outbreaks suggest that only isolates 
with indistinguishable profi les should be included into infections cluster, and profi les with 2-3 
diff erences in the band position could be included if the outbreak persists for long time or if 
the infections are recognized as secondary infections due to person-to-person spread [309]. 
Th erefore, the similarity of PFGE profi les should not be considered alone as a measure for genetic 
distance and the PFGE results should always be evaluated together with the epidemiological data. 
Multilocus variable-number tandemrepeat analysis (MLVA)
MLVA is based on size polymorphisms in a certain variable number of tandem repeat (VNTR) 
areas within the bacterial genome [322]. Th ese VNTR units mutate rapidly which enables the 
study of genetic relatedness between isolates [323]. Th ey can locate in coding and non-coding 
regions in the genome. Th e number of repeats can be determined by PCR amplifi cation and 
following fragment analysis by capillary electrophoresis. Th e use of fl uorescently labeled primers 
in the capillary electrophoresis allows all amplicons to be analyzed in one run. In comparison 
to conventional agarose gel electrophoresis, the amplicon size can be much more accurately 
determined by DNA sequencer. Using computer soft ware (freely available e.g PeakScanner), all 
loci can be distinctly recognized according to the dye colors, and based on the size of the PCR-
product, the exact number of repeats for each MLVA loci can be calculated. Aft erwards, an allele 
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number corresponding to the number of repeats of specifi c MLVA locus can be given (e.g 3-16-
NA-NA-0311) and the MLVA profi le can be easily internationally compared [324].
MLVA is one of the most common genotyping method used for public health surveillance and 
epidemiological investigations of Salmonella (serovars Typhimurium and Enteritidis) and EHEC 
O157 [321, 325-328]. Advantages of MLVA include speed, high discriminatory power and 
reduced handling times of pathogenic organisms. In comparison to PFGE, it is cheaper, can be 
automated and the generated data are easier to interpret [313]. Th e drawbacks of MLVA include 
a species-specifi c protocol meaning that the same MLVA scheme is not equally discriminative 
between species or between diff erent Salmonella serovars. Currently in the EU, well-standardized 
and general accepted MLVA protocols exist for only S. Typhimurium [324] and S. Enteritis 
[325]. Furthermore, for these two serovars a set of reference strains with verifi ed fragment sizes 
is available allowing for normalization and direct comparison between laboratories. However, 
diff erences in the choice of loci and the nomenclature may confuse the inter-laboratory 
comparison (Table 7). Several MLVA typing scheme have been developed for the typing of EHEC 
O157 [329-331] and for some non-O157 serotypes [332, 333]. Also, some studies on generic 
MLVA for all E. coli isolates have been proposed [334]. Similar to PFGE, there is a need for clear 
guidelines on how to interpret MLVA results in outbreak situations. An acceptable diff erence 
in the number of repeats in one or more loci should be defi ned. Th e size diff erence in a VNTR 
locus does not always refl ect the real number of repeats because insertion and deletions due to 
occasional DNA polymerase mistakes may occur during the outbreak [322, 335]. A recent study 
on S. Enteritidis suggested that PFGE together with MLVA would provide the most effi  cient 
subtyping [336].
In contrast to PCR-based MLVA typing, an alternative strategy for epidemiological typing by 
MLVA is the DNA sequencing of the produced amplicons. Sequencing-based methods for VNTR 
determination have been developed for example for Vibrio cholera [337]. However, sequencing 
is not widely used since specifi c equipment is required and it would be more expensive than 
capillary electrophoresis.
Table 7: Nomenclature of MLVA loci for Salmonella Enteritidis and Typhimurium in Europe and the 
USA.
S. Enteritidis VNTR loci S. Typhimurium VNTR loci Europe PulseNet USA
SET533 SENTR7 SE9
SET2073 SE3 SE3
SET2504 SENTR4 SE1
SET3073 SENTR5 SE5
SET3511 NA SE6
SET4617 SENTR6 SE2
STM2730 STTR6 ST5
STM3184 STTR5 ST6
STM3246 STTR9 ST7
STM3629 STTR3 ST8
  pSLT53 STTR10 STTR10
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Multilocus sequence typing (MLST)
MLST is based on the principles of phenotypic multilocus enzyme electrophoresis (MLEE) which 
fi rst revealed the clonal nature of some bacteria [338]. In MLST, multiple (usually fi ve to seven) 
highly conserved housekeeping genes are amplifi ed by PCR and sequenced [339]. For each gene, 
a specifi c sequence type is assigned based on the alleles. Moreover, isolates can be clustered into 
clonal complexes based on their sequence types. Since housekeeping genes are robust and under 
limited selective pressure, MLST is a valuable tool in evolutionary studies and population genetic 
analyses [313]. Other advantages of MLST include that it has high typeability, it is reproducible, 
and internet-based MLST databases (e.g www.mlst.net) allow standardized nomenclature and 
inter-laboratory comparison. Several studies on Salmonella [340-342] and E. coli [329, 343] have 
revealed that the discriminatory power (especially the ability to discriminate between isolates 
of the same serovar) of MLST is low. Also, the relative high cost of separate gene sequencing 
hinders the use of MLST typing in the routine surveillance of foodborne pathogens. In order to 
improve the discriminatory power of traditional MLST, protocols which additionally included 
more rapidly changing genes such as temperate phages [290] or virulence genes [340] have been 
developed. In general, the discriminatory power was not higher than by traditional MLST [340, 
344]. In the near future MLST might be replaced with WGS typing.
Future molecular typing methods
Novel molecular subtyping methods based on single-nucleotide polymorphismus (SNP) using 
Sanger sequencing and whole genome sequencing (WGS) have been applied for characterization 
of foodborne pathogens [345]. SNP method is based on random single-nucleotide mutations 
that happen independently over time throughout the bacterial genome. Th e diff erences in the 
number of SNPs between two organisms defi ne the genomic distance between the isolates 
and this relationship has been used in outbreak investigations of Salmonella and EHEC [346, 
347]. In comparison to Sanger sequencing, WGS allows the discovery of SNPs across the 
bacterial genome [348]. WGS can be applied for species identifi cation [349], genotyping [350], 
determination core genome or virulence genes and for outbreak investigations [351-353]. Next 
generation sequencing approaches have made WGS widely available, and due to new and easy to 
handle bench-top sequencers, even small microbiological laboratories are able to do sequencing 
by themselves. In the near future WGS will be aff ordable, fast and simple to use and will be 
an increasingly attractive method for strain characterization and typing. Th e potential of WGS 
was demonstrated in 2011 during the German outbreak caused by multi-drug resistant EAHEC 
O104:H4 -contaminated sprouts. Th e sequencing of samples from an early stage of the outbreak 
suggested that the outbreak had a clonal origin [277]. Further analysis indicated that the outbreak 
strain had originated from an EAEC O104:H4 backbone, and by gain and loss of chromosomal 
and plasmid-encoded virulence factors there emerged a highly pathogenic hybrid of EAEC 
and EHEC [277]. In addition, the isolates from this large German outbreak were compared to 
the isolates from a smaller French outbreak, suggesting that  there were no direct transmission 
between these populations, but instead both outbreaks emerged by diff erent transmission 
routes from the same fenugreek sprout seed batch [354]. Th e major challenges of WGS will be 
the harmonization of the WGS pipelines and protocols (comparable and high quality data) and 
the extraction of needed information from the large amount of detailed information available. 
Moreover, once sequenced, the data can be easily reanalyzed and tailored based on interest and 
study design or if new soft ware programs are available in the future. In addition, to compare 
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results obtained with WGS and results obtained by traditional methods, it is important to be 
able to evaluate the concordance of the methods [348]. As with any genotyping method used for 
outbreak investigations, WGS data should be linked with epidemiological data.
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3  AIMS OF THE STUDY
Th e aims of this study were:
1. to apply genotyping for outbreak investigation and trace back the sources of human 
Salmonella and EHEC infections.
2. to investigate the diversity of Salmonella and EHEC isolates from domestically acquired 
infections in Finland.
3. to evaluate MLVA method for epidemiological typing purposes of Salmonella Typhimurium.
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4  MATERIAL AND METHODS
Th e material and methods used in this study are summarized in Table 8 and 9. Materials and 
methods are described in detail in the original articles (I, II, III and IV).
4.1  Salmonella and EHEC strains (I-IV, unpublished data)
Table 8: Bacterial strains used in this thesis (from the strain collection of THL, Finland). 
Organism (serovar/serotype) Selection criteria for 
isolates
Isolation 
year
No. of 
isolates
Study
Salmonella (Agona Enteritidis, 
Give, Hvittingfoss, Infantis, 
Newport and Typhimurium)
Strains from seven most 
common salmonella 
serovars in Finland were 
chosen for phenotype 
microarray.
1995 29 I
Salmonella (Newport and 
Reading)
All strains related to 
nationwide S. Newport/S. 
Reading outbreak in 
Finland were studied
2008 77 II
Salmonella (Typhimurium) All domestic S. 
Typhimurium strains  (one 
strain/patient,  clusters or 
outbreaks excluded) were 
studied
Nov 2007- 
Dec 2012
375 III
EHEC (O78:H-) Family cluster: EHEC 
strains isolated from stool 
and blood of the fi ve family 
members
2009 6 IV
Salmonella Domestically acquired 
infections 
2007-2014 2337 Unpublished
EHEC  Domestically acquired 
infections
2007-2014 175 Unpublished
4.1.1  Strains isolated from domes? cally acquired Salmonella and EHEC 
infec? ons 
All Salmonella and EHEC strains isolated in Finland during 2007-2014 from patients that 
had not been abroad recently (within one week prior onset of symptoms) were studied. 
Clinical laboratories across Finland are obligated to report all Salmonella and EHEC fi ndings 
to the NIDR at the THL and send all isolates to the Bacterial Infections Unit for verifi cation 
and further typing. In Finland, all patients with EHEC infection are interviewed about their 
travel history, diet, symptoms and connection to farms, and the contact persons and farms 
are sampled.
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4.2  Methods
Table 9: Methods used in this thesis. Roman numerals refer to the publications in which the methods are 
used and described in detail.
Methods Organism Described  in 
publication
Phenotyping methods
Antimicrobial susceptibility testing with disc diff usion 
method
Salmonella/EHEC I, II, III, IV
API 20E test/sorbitol fermenting EHEC IV
Minimum inhibitory concentration test Salmonella III
Phage typing Salmonella I, III
Phenotype microarray Salmonella I
O:H serotyping Salmonella/EHEC I, II, III, IV
Toxin production by VTEC-RPLA EHEC IV
Genotyping methods
16-plex PCR EHEC IV
5-plex PCR (stx1, stx2, eae, hlyA and saa) EHEC IV
Multilocus variable number tandem repeat analysis 
(MLVA) with VNTR loci STTR3, STTR5, STTR6, STTR9 
and STTR10p
Salmonella III
Pulsed-fi eld gel electrophoresis (PFGE) with XbaI Salmonella and EHEC I,II, III, IV
stx1 gene detection by sequencing EHEC IV
Other methods
Statistical methods Salmonella I, III
Case-control-study Salmonella II
4.2.1  Changes in an? microbial suscep? bility tes? ng of Salmonella and 
EHEC during this study (I, II, III, IV and unpublished data)
During this study, the antimicrobial susceptibility to 12 antimicrobials was determined by the 
agar diff usion method on Müller-Hinton II agar: ampicillin (A) (10 μg), chloramphenicol (C) (30 
μg), streptomycin (S) (10 μg), sulphonamide (Su) (300 μg), tetracycline (T) (30 μg), ciprofl oxacin 
(Cp) (5 μg), trimethoprim (Tm) (5 μg), gentamicin (G) (10 μg), nalidixic acid (Nx) (30 μg), 
cefotaxime (Ct) (5 μg), mecillinam (M) (10 μg) and imipenem (I) (10 μg). However, for 2007-
2010, the protocols and breakpoints of the Clinical and Laboratory Standards Institute (CLSI) 
and for 2011-2014 those of the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST) (http://www.eucast.org/) were applied. Minimum inhibitory concentration (MIC) 
for ciprofl oxacin (from 0.002 to 32 mg/L) was detected by E-Test (bioMérieux, Marcy l’Etoile, 
France)  for the strains that were resistant (R) or intermediate resistant (I) to nalidixic acid. 
Ciprofl oxacin MIC breakpoint ≤0,06 mg/L was interpreted as susceptible (http://www.eucast.
org/). Multi-drug resistance (MDR) was defi ned as resistance to four or more antimicrobial 
groups.
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4.2.2  Changes in Salmonella Typhimurium MLVA during this study (III 
and unpublished data)
Th e MLVA method was set up in THL in November 2007.  For that, the calibration of MLVA was 
performed using 33 S. Typhimurium strains (the MLVA calibration set was obtained from SSI 
(Statens Serum Institute, Denmark). Between November 2007 and December 2012 MLVA was 
performed as described in study III to all S. Typhimurium strains isolated from domestically 
acquired infections. Since January 2013, the MLVA method was adjusted according to the 
protocol of European Centre for Disease Prevention and Control (ECDC) and some changes in 
primer labeling was performed (Table 10). Both, the fl uorescent-labeled forward primers and 
unlabeled reverse primers, were obtained from Applied Biosystems (CA, USA). Th e calibration 
of MLVA was repeated when primers were changed. Th e new fl uorescent labels showed no eff ect 
on fragment size in capillary electrophoresis using the 33 reference strains. In paragraph 5.1.2 
the MLVA results obtained with both sets of primer labels are presented. For the MLVA (Nov 
2007-Dec 2012 described in study III and Jan 2013-Dec 2014 described in this study 5.1.2) the 
strain selection criteria was following: one strain per patient was chosen and known epidemics 
and family clusters were excluded.
Table 10: Fluorescence labels used in MLVA analysis at THL. 
MLVA primers Fluorescent labels during 1st of November 
2007 to 31st of December 2012
Fluorescence labels since 1st of 
January 2013 (ECDC protocol)
STTR-3 forward NED PET
STTR-5 forward NED VIC
STTR-6 forward FAM FAM
STTR-9 forward FAM FAM
STTR-10 forward PET NED
4.2.3 Phage typing of EHEC O157 (done for unpublished strains)
For phage typing, one bacterial colony of EHEC O157 were grown in double-strengt nutrient 
broth (Difco laboratories, Dietroit, USA) for 1.5 hours at 37°C and 80 rpm, and fl ooded onto 
double-strengt nutrient agar plates (Difco). Th e 16 EHEC O157 specifi c bacteriophages used in 
this study were obtained from Public Health England, formel HPA. Phage-typing was carried 
out as described by Ahmed et al. [288] and extended by Khakhria et al. [355].  Th e results were 
analysed using a reference table in which 66 confi rmed and 14 provisional phage types and lytic 
reaction are listed. 
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5  RESULTS
5.1  Pheno- and genotypic characteris? cs of certain Salmonella 
serovars (I-III and unpublished data) 
5.1.1  The most common Salmonella serovars and phage types among 
domes? cally acquired infec? ons 2007-2014
During 2007-2014, there were a total of 2,818 (15%) reported domestic Salmonella infections 
among all 18,303 reported Salmonella infections in Finland. Th e incidence of domestic Salmonella 
infections varied beetween 5.4-7.5/100,000 inhabitants being highest in 2012 and lowest in 
2014. Th e three most common serovars were Typhimurium (891 strains, 32%), Enteritidis (436 
strains, 15%) and group B (155 strains, 6%) (Fig. 5). Th e majority of S. group B are monophasic 
Typhimurium. During 2007-2014, a total of 131 diff erent Salmonella serovars were isolated from 
domestically acquired human infections but only six serovars (Typhimurium, Enteritidis, group 
B, Agona and Infantis) comprised 65% of the 2,818 serotyped domestic Salmonella strains. A 
clear seasonal trend in confi rmed salmonellosis cases was observed, with most cases reported 
during the late summer months (Fig. 6). 
Results
Figure 5: Th e most common serotypes among domestically acquired Salmonella infections in 
Finland 2007-2014 (one strain/patient).
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Figure 6: Th e seasonal trend of domestically acquired Salmonella infections in Finland.
All the domestic S. Typhimurium and S. Enteritidis and strains were phage typed. Among S. 
Typhimurium strains (including clusters and outbreaks), DT1, RDNC and DT104 were the 
most common phage types. Th e most frequently detected phage types among the domestically 
acquired S. Enteritidis infections were PT8, PT1B and PT4. Since the 60’s endemic phage type 
DT1 has caused infections and small epidemics in Finland. During 2007-2014, 37% of all 
domestic S. Typhimurium infections were caused by DT1. Th e number of domestically acquired 
S. Typhimurium infections has decreased during the study period. Meanwhile, the number of 
infections caused by domestic monophasic S. Typhimurium has increased since 2011 (Fig. 7). 
During 2012-14, a total of 84 PCR confi rmed monophasic S. Typhimurium strains were detected 
among domestically acquired infections, and the most common phage types were DT193 in 
2012, DT195 in 2013 and DT120 in 2014. Th e majority of S. Typhimurium and S. Enteritidis 
strains (both approximately 60%) were susceptible against all tested antimicrobials whereas only 
10% of S. group B were fully susceptible.
Results
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Figure 7: Trends of domestic S. Typhimurium (2007-2013), endemic S. Typhimurium DT1 
(2007-2013) and monophasic S. Typhimurium (2009-2013).
5.1.2  Distribu? on of suscep? ble and mul? -resistant strains among 
phage types in domes? c Salmonella Typhimurium infec? ons 
between Nov 2007-Dec 2014 (III, unpublished data)
During Nov 2007-Dec 2014, a total of 546 sporadic S. Typhimurium strains isolated from 
Finns, who had not traveled abroad recently, were typed by phage typing and antimicrobial 
susceptibility testing. One strain per patient was included and epidemics and family clusters 
were excluded from the study. Among the strains, 31 distinct phage types were detected (Table 
11).  Of all strains, 78% (426 strains) were assigned to the fi ve most common DTs: DT1 (43% 
of the strains), RDNC (16% of the strains), U277 (8% of the strains), DT104 (7% of the strains) 
and DT120 (4% of the strains). Th e majority of the strains (62%) were susceptible to all tested 
antimicrobials. However, 12% of the S. Typhimurium strains were MDR (resistant to at least four 
antimicrobials when a set of 12 antimicrobials were tested by the disk diff usion test). Among 18 
phage types (DT2, DT7, DT7A, DT8, DT9, DT10, DT15A, DT40, DT40, DT41, DT69, DT82, 
DT99, DT132, DT136, U277, U287, U310), none of the strains were MDR. In contrast, all strains 
of phage types DT104B and U311 were MDR. Of all non-susceptible strains for nalidixic acid, 
25 strains had a decreased susceptibility to ciprofl oxacin (MIC values were ranging from 0.125 
to 4 mg/L). Decreased susceptibility to ciprofl oxacin was observed among 15 DT104 (0.125-
0.25 mg/L), four U311 (0.125-0.5 mg/L), two DT120 (0.25-0.5 mg/L), two NT (0.25-0.5 mg/L), 
one DT104B (4 mg/L) and one U310 (0.5 mg/L) strains. In comparison, only one domestic 
monophasic S. Typhimurium strain was fully susceptible (DT193 in 2013) and 96% of all strains 
were MDR. Resistance to ampicillin, streptomycin, sulfonamide and tetracycline (R-type ASSuT) 
was the most frequent (77%). In addition, the increase of resistance to nalidixic acid was evident 
in 2014 (9 strains) compared to 2012-2013 (1 strain each year). 
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Table 11: Distribution of phage types and antimicrobial resistance among 546 S. Typhimurium 
strains isolated from sporadic infectionsin Finland, Nov 2007- Dec 2014.
Phage types  (No. 
of strains)
No. of susceptible strains (% of 
strains within each phage type)
Multidrugresistance (MDR) profi les (no. 
of strains)*
DT1 (233) 172 (74%) ASSuTm (1)
U277 (44) 38 (86%) -
DT104 (40) 3 (8%) ACSSuTNx (14), ACSSuT (6)
DT120 (23) 6 (26%) ACSSuT (8), ASSuT (4)
DT41 (15) 12 (80%) -
DT116 (14) 9 (64%) ASSuTTm (2), ASSuT (1)
U302 (11) 5 (45%) ACSSuTGM (2), ACSSuTG (1), ACSSuT (1)
DT195 (11) 2 (18%) ASSuT (2), ACSSuTCt (1)
DT104B (10) 0 ASSuT (4), ACSSuT (4), ACSSuTTm (1), CSSuTGNx (1)
DT193 (8) 0 ASSuT (1), ACSSuT (1), ASSuTTm (1)
DT2 (6) 4 -
DT12 (6) 2 ACSSUT (2)
DT10 (5) 4 -
DT135 (5) 3 ASSuTTm (2)
U282 (4) 4 -
U311 (4) 0 ACSSuT (1), ASuTNx (1), ASSuTNx (1), ACSSuTTmNx (1)
DT15A (3) 1 -
NT (3) 1 ASSuTTmNx (1)
DT8 (2) 1 -
DT9 (2) 0 -
U312 (2) 1 -
DT7, DT7A, 
DT40, DT69, 
DT99, DT132, 
DT136, U287, 
U310 (1 strain of 
each type)
7 -
RDNC (86) 66 (77%) SSuT (1), ACSuTTm (1), ASSuT (1)
A total of 31 DTs 
were identifi ed
Of all strains, 341 (62%)  were 
susceptible to all 12 antimicro-
bials
Of all strains, 68 (12%) were MDR
*ampicillin (A), chloramphenicol (C), streptomycin (S), sulphonamide (Su), tetracycline (T), 
trimethoprim (Tm), gentamicin (G), nalidixic acid (Nx), cefotaxime (Ct), mecillinam (M).
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5.1.3  MLVA subtypes among domes? c Salmonella Typhimurium strains 
(III, unpublished data) 
During November 2007-December 2014, 546 sporadic Salmonella Typhimurium strains isolated 
from Finns who had not been abroad recently were subtyped by 5-loci MLVA. One strain per 
patient was included and known epidemics and family clusters were excluded from MLVA 
analysis. Th e studied strains belonged to 31 diff erent phage types and were divided into 170 
distinct MLVA types. All strains were typeable with 5-loci MLVA and the Simpson’s diversity 
index (DI) for MLVA was 0.891. Th e minimum spanning tree (MST) of the MLVA results showed 
that the Finnish S. Typhimurium strains clustered together (Fig. 8). Th e three most common 
profi les (3-16-NA-NA-0311, 3-15-NA-NA-0311 and 3-17-NA-NA-0311, red circles in the Fig. 8) 
counted for 47 % of the strains indicating that domestic strains were homogenous. XbaI-PFGE 
profi le STYM1 was the most common among the domestic DT1 strains and STYM8 among the 
U277 strains. STYM1 profi le (146 strains) was divided into 12 MLVA types and STYM8 into 9 
MLVA profi les (Table 12). Among STYM1 and STYM8, the MLVA profi le 3-16-NA-NA-0311 
was the most common.
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Figure 8: MST of MLVA types (546 
sporadic S. Typhimurium isolates from 
domestically acquired infections). 
Categorical coeffi  cient was used to 
construct the MST. Each circle in the 
tree represents a diff erent MLVA type. 
Heavy, short lines connecting two MLVA 
types denote types diff ering by a single 
MLVA locus. Th e halos extending over 
the various types denote the grouping 
by Bionumerics analysis. Th e color and 
size of a circle indicate the numbers of 
the strains with a particular MLVA type: 
light blue: 1 strain; yellow: 2-5 strains; 
orange 6-30 strains and red: >30 strains. 
Th e most common MLVA types are 
marked with red and orange dots.
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Table 12: MLVA types among the two most common XbaI-PFGE profi les among sporadic domestically 
acquired Salmonella infections, Nov 2007- Dec 20014.
Xbal-PFGE profi le No. of strains MLVA type No. of strains
STYM1
 
146
 
3-16-NA-NA-0311 85
3-15-NA-NA-0311 20
3-17-NA-NA-0311 9
3-16-NA-NA-0211 7
3-15-NA-NA-0211 7
3-18-NA-NA-0311 6
3-13-NA-NA-0311 4
3-6-NA-NA-0311 3
3-14-NA-NA-0311 2
3 MLVA types (1 strain each) 3
  total 12 MLVA types 146
STYM8 34 3-16-NA-NA-0311 12
3-18-NA-NA-0311 6
3-16-NA-NA-0211 5
3-15-NA-NA-0311 5
3-14-NA-NA-0311 2
    4 MLVA types (1 strain each) 4
  total 9 MLVA types 34
NA=no amplifi cation
5.1.4  Metabolic characteris? cs of certain Salmonella enterica (I) 
Phenotype microarray (PM) plates 1-10 containing 949 substrates were tested for six S. 
Typhimurium and two S. Agona strains and all tests were performed in duplicate. Only a few 
substances led to diff erences in the phenotype. Among S. Typhimurium, 15 substrates (m-tartaric 
acid, m-inositol, glyoxylic acid, d-galactonic acid γ-lactone, l-alanine, l-rhamnose, itaconic, 
l-proline and the dipeptides Leu-Ala, Ala-Ala, Ala-Val Tyr-Ala, Trp-Glu, Asp-Trp Met-Phe) 
showed diff erences in the metabolic activity (In stydy I). Interestingly, S. Typhimurium phage 
types DT1, DT40 and DT104 diff ered in their carbon utilization characteristics when tested with 
m-tartaric acid (Fig. 9). DT104 strain could not assimilate glyoxylic acid and m-inositol as carbon 
sources. Th e strains of XbaI-PFGE profi le STYM1 diff ered on itaconic acid, l-proline, Trp-Glu, 
Asp-Trp, and Met-Phe. Furthermore, S. Agona diff ered from S. Typhimurium on d-tagatose (Fig. 
10). Th e studied S. Typhimurium strains were typeable by PM assay and reproducible respiratory 
activity was measured in two independent experimental run. Other studied Salmonella serovars 
showed even less metabolic diversity in PM analysis.
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Figure 9: Th e ability of six diff erent S. Typhimurium strains to utilize m-tartaric acid as a 
carbon source was measured in duplicate sets. Th e analyzed strains belong to the phage types 
DT1 (IH67000, FE86302, FE82699 and IH120618), DT40 (FE85448) and DT104 (FE86268). 
Th is graphic presentation uses the area under the curve (AUC) values obtained when the color 
change was measured in every 15 min using OmniLog soft ware. S. Typhimurium DT104 was 
unable to utilize m-tartaric acid as a substrate whereas S. Typhimurium DT40 and DT1 were 
able to metabolize the substrate at intermediate and high rates, respectively.
Results
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Figure 10: Th e respiratory profi les of S. Typhimurium strains IH67000, FE86302, FE82699 
and IH120618 (phage type DT1), FE85448 (phage type DT40) and FE86268 (phage type 
DT104) and S. Agona isolates FE80600 and IH262304 based on AUC values in duplicate 
measurements. S. Agona stains showed no respiratory activity on d-tagatose (A), d-galactonic 
acid γ–lactone (B) and delayed activity on l-proline (C).
Patients and Methods
41
5.2  XbaI-PFGE pro? les in the outbreak inves? ga? on of Salmonella 
Newport and Salmonella Reading infec? ons (II)
In 2008, a nationwide outbreak caused by S. Newport and S. Reading aff ected 107 persons in 
Finland. Th ree temporal and geographical clusters with an epidemiological link were identifi ed, 
and in stool sample of one patient from Lapland cluster both serotypes were isolated (Study II, 
Fig. 2). A total of 77 culture-confi rmed S. Newport cases and 30 S. Reading ones were identifi ed. 
All 77 outbreak-related S. Newport strains belonged to the same XbaI-PFGE profi le SNWP59 
(SNWPXB.0068) (Table 13). 
Table 13: S. Newport and S. Reading genotypes associated to the outbreak. Th e analyzed 
sample types were feces (F), urine (U) and blood (B).
Serotype Xbal-PFGE profi le No. of strains Sample type 
S.Newport (6,8:e,h:1,2) SNWP59 77 F (67), U (6), B (4)
S. Reading (4,12:e,h:1,5) SREA4 3 F (2), B (1)
SREA5 23 F (20), U (2), B (1)
SREA6 3 F (2), B (1)
  SREA7 1 F (1)*
* Double infection
Four distinct XbaI-PFGE profi les were detected among the S. Reading SREA4-7, no international 
names available (Fig. 11). Of them, the most common XbaI-PFGE profi le was SREA 5 (23 
strains). Th e SREA5, 6 and 7 profi les diff ered from each other in one to two band positions in 
the PFGE analysis. SREA4 diff ered by more than 10 banding positions from SREA5, 6 and 7. Th e 
SREA5, 6 and 7 profi les showed a genetic similarity of 95%. Taking the strains with SREA4 into 
account, a genetic similarity of about 75% was shown in the UPGMA dendrogram (Fig. 11). One 
patient had a double-infection with both Salmonella serovars, the strains had Xbal-PFGE profi les 
SNWP59 and SREA7. 
Figure 11: UPGMA dendrogram of four diff erent S. Reading XbaI-PFGE profi les related to studied 
outbreak (SREA4-7).
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5.3  Occurrence and characteris? cs of clinical isolates of EHEC in 
Finland (IV, unpublished data) 
In 2007-2014, microbiologically confi rmed EHEC infections were detected among 271 patients. 
Th e majority of them (188 strains, 69%) were isolated from domestically acquired infections 
(Fig. 12). 
Figure 12: Th e proportions of domestically acquired and travel-related EHEC infections in Finland, 
2007-2014.
Of the 188 domestically acquired infections, 112 strains (60%) were of serotype O157:H7/H- and 
the remaining 76 strains belonged to non-O157 serotypes (Fig. 13). Th e majority of the O157 
strains were sorbitol-negative (70 strains) and the most common non-O157 serotypes were 
O26:H11/H-, O103:H2/H- and O145:H28/H- (Fig. 14).
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Figure 13: Trends of microbiologically confi rmed EHEC infections in Finland 2007-2014. 
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Figure 14: Most common EHEC serotypes isolated from domestically acquired infections.
5.3.1  Domes? c EHEC O157 strains 
Among all EHEC serogroup O157 strains, eight phage types (PTs) were identifi ed (Fig. 15). Th e 
majority of O157 strains (63%) were unable to ferment sorbitol. Th e three most common phage 
types were PT88 (42/112, 37%) and PT8 (39/112, 35%) and PT2 (19/111, 17%). PT88 was the 
most common phage type among the sorbitol-positive (sor+) and PT8 among sorbitol-negative 
(sor-) O157 strains. Th e majority of the O157:H7/H- were susceptible to all tested antimicrobials 
(96%) and only four sorbitol negative O157 strains were MDR (R-type SSuTTmNx) when a set 
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of 12 antimicrobials were tested in an disk diff usion test. Th e strains were divided into 37 district 
XbaI-PFGE profi les. Th e most common XbaI-PFGE profi le (1.203, 21 strains) has been detected 
among several small national outbreaks (Table 17 and Fig. 16)
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Figure 15: Distribution of EHEC O157 phage types among domestically acquired infections during 
2007-2014.
Only two diff erent virulence gene combinations were detected. Of all domestic O157 strains, 
67 strains (60%) carried a virulence gene combination stx2, eae and hlyA and 45 strains (40%) 
possessed the gene combination stx1, stx2, eae and hlyA (Table 14). Th e strains of sor+ O157:H- 
showed only one virulence gene combination (stx2, eae, hlyA). None of the EHEC O157 strains 
had stx1 gene only or saa gene.
Table 14: Virulence gene profi les of EHEC O157 strains isolated from domestically acquired 
infection during 2007-2014.
Domestic EHEC O157:H7/H- No. of strains 
Sor+ O157:H-
stx2, eae, hlyA 42
Sor- O157:H7/H-
stx2, eae, hlyA 25
stx1, stx2, eae, hlyA 45
Total 112
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5.3.2  Domes? c EHEC non-O157 strains 
During 2007-2014, 76 human EHEC non-O157 infections of domestic origin were detected. 
Th ese strains belonged to 22 district O:H serotypes (Table 15). Th e three most common non-
O157 serotypes were O26:H11/H- (16 strains), O103:H2 (12 strains) and O145:H28/H- (11 
strains). Two strains remained non-typeable (ONT). Th e majority of the non-O157 strains were 
susceptible to all tested antimicrobials (60%) and 11% were MDR when a set of 12 antimicrobials 
tested by the disk diff usion test. All domestic EHEC non-O157 strains were sor+, except four 
strains of serotypes O121:H19 (n=1), O117:H7 (n=2) and ONT:H49 (n=1) were sor-. Genotyping 
divided the EHEC non-O157 strains into 54 diff erent XbaI-PFGE profi les. Th e most common 
XbaI-PFGE profi les were associated to known small family clusters.
Table 15: EHEC non-O157 serotypes of domestic origin during 2007-2014.
Non-O157 serotype Year Total
 2007 2008 2009 2010 2011 2012 2013 2014
O26:H11 1     2   1 9 2 15
O103:H2   1 4     1 2 4 12
O145:H-       3 4 2   1 10
O121:H19       1 3     2 6
O78:H-     6           6
O5:H-   3             3
O146:H28             3   3
O55:H7     1       2   3
O117:H7           2     2
O182:H25       2         2
O146:H21       1       1 2
ONT               2 2
10 serotypes (1 each) 1   2 1 4   2   10
Total 2 4 13 10 11 6 18 12 76
Among the non-O157 strains, eight diff erent virulence gene combinations were detected (Table 
16). Th e most of the strains carried common stx1 only (42 strains, 55%) followed by stx2 only 
(32 strains, 42%). Only two strains carried both stx1 and stx2 genes. Th e most common virulence 
gene combinations were stx1, eae and hlyA (43% of the strains) and stx2, eae and hlyA (30% of the 
strains). Only one EHEC strain (ONT:H-) carried the gene saa. Among 15 strains of the most 
common non-O157 serotype O26:H11, two virulence gene profi les were detected, of which the 
combination stx1, eae, hlyA was the most common (10 strains) and remaining fi ve strains carried 
the genes stx2, eae, hlyA. In contrast to the strains of O26:H11, one strain of serotype O26:H- 
carried both stx1 and stx2 genes. All 12 strains of serotype O103:H2 and 10 strains of O145:H- 
showed a single virulence gene combination stx1, eae and hlyA and stx2, eae, hlyA. In comparison 
to O145:H- which possessed the genes stx2, eae and hlyA, one O145:H28 strain had the genes stx1, 
eae and hlyA.
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Table 16: Virulence gene profi les of EHEC non-O157 strains isolated from domestically 
acquired infection during 2007-2014.
Domestic EHEC non-O157 No. of strains 
stx1 3
stx1, hlya 6
stx1, eae, hlyA 33
stx2 6
stx2, eae 2
stx2, eae, hlyA 23
stx2, hlyA, saa 1
stx1, stx2, eae, hlyA 2
Total 76
5.3.3  Detected outbreak and family clusters caused by EHEC in Finland, 
2007-2014 
Most of the EHEC infections in Finland are sporadic or family-related secondary infections. 
During 2007-2014, 15 family-related small clusters and four outbreaks were detected (Table 17). 
On October 2009, a family-related cluster (5 patients) caused by a rare EHEC O78:H– strain 
was observed. Th e strain harbored stx1c and hlyA genes and was detected in blood and stool 
samples of a 2-week-old neonate who had bacteremia and HUS and in the stool samples of his 
asymptomatic family members. All strains were susceptible to tested antimicrobials and showed 
indistinguishable XbaI-PFGE profi les (Fig. 1 in study IV). Th e source of the infection was not 
known. In June 2012, eight persons (six children and two adults) contracted an EHEC infection 
(sorbitol-positive, O157:H-, phage type PT88, XbaI-PFGE profi le 1.192) in the Turku region (Fig. 
16). Five out of six children were hospitalized because of HUS. Th e patients had visited a local 
farm and/or consumed unpasteurized milk from that farm. An identical EHEC strain was found 
in the cattle feaces on the farm and in environmental samples from the farm. In April-May 2013, 
13 persons were infected with an EHEC (sorbitol-positive, O157:H-, PT88, XbaI-PFGE profi le 
1.203a) nationwide in Finland (Fig. 16). Th e majority of the patients (11/13) were children 
and seven of them developed HUS. Interviews conducted did not reveal any particular food 
common for the cases. According to the expert network of the ECDC, no similar bacterial strain 
had been found in other EU countries or in the USA. Th e second outbreak in 2013 occurred in 
Lohja, where an outbreak caused by sorbitol-negative EHEC O157:H7, PT2, XbaI-PFGE profi le 
1.211 strain was isolated from feaces of eight day care children and from nine of their family 
members (Fig. 16). None of them developed HUS. Day care food was identifi ed as connecting 
factor between the patients, but the source of the infections remained unidentifi ed. On Dec 
2013, sorbitol-negative EHEC O157:H7:PT8:stx1,stx2,eae,hlyA strain was isolated from feaces 
of 5 family members with farm contact and from a asymptomatic person who had worked in 
that farm in Loviisa region. Th e source remained unknown. Between Dec 2013 and Jan 2014, a 
sorbitol-positive EHEC O157:H-, PT88, strain was isolated from feaces of 12 patients nationwide. 
Eight of them had an identical XbaI-PFGE profi le 1.203b (Fig. 16). Th e source of infections 
remained unidentifi ed. 
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Table 17: Family-related clusters and outbreaks deteted in Finland during the period of 2007 
to 2014.
Serotype Phage type Virulence genes Xbal-PF-
GE
No. of 
patiens
Clusters Suspected source
O157:H- PT8 stx1, stx2, eae, hlyA 1.29 3 Family cluster Unknown
O5:H-   stx1, eae, hlyA O5a 3 Family cluster Unknown
O103:H2 stx1, eae, hlyA O103p 3 Family cluster Unknown
O78:H-   stx1, hlyA O78a 5 Family cluster Unknown
O26:H11   stx2, eae, hlyA O26j 2 Family cluster Unknown
O157:H- PT88 stx2, eae, hlyA 1.151 2 Family cluster Unknown
O121:H19   stx2, eae, hlyA O121c 2 Family cluster Unknown
O157:H7 PT8 stx1, stx2, eae, hlyA 1.122 2 Family cluster Unknown
O157:H- PT88 stx2, eae, hlyA 1.192 8 Local epidemic Unpasteurized milk 
/ animal contact
O157:H- PT88 stx2, eae, hlyA 1.203 13 Nationwide 
epidemic
Widely sold food
O157:H7 PT2 stx2, eae, hlyA 1.211 17 Local epidemic Day care food
O157:H7 PT8 stx1, stx2, eae, hlyA 1.164 5+1 Family cluster 
& farm worker
Farm contact
O157:H7 PT8 stx1, stx2, eae, hlyA 1.29 3 Family cluster Unknown
O26:H11 stx1, eae, hlyA O26r 3 Family cluster Unknown
O26:H11 stx2, eae, hlyA O26s 2 Family cluster Unknown
O103:H2   stx1, eae, hlyA O103s 3 Family cluster Unknown
O157:H- PT88 stx2, eae, hlyA 1.203 8* Nationwide 
epidemic
Unknown
O157:H7 PT8 stx1, stx2, eae, hlyA 1.29 2 Family cluster Unknown
O121:H19   stx2, eae, hlyA O121e 2 Family cluster Unknown
* Isolation date 13.12.2013-10.02.14
Figure 16: Geographical locations of detected 
outbreaks caused by EHEC in Finland (2007-2014).
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6  DISCUSSION
Foodborne diseases cause a wide spectrum of illnesses and are a public health problem 
worldwide, also in industrialized countries. Salmonella is the second most common agent 
of foodborne disease and EHEC is rare but is associated to severe disease. Futhermore, these 
bacteria are able to gain additional virulence factors by horizontal gene transfer which might 
lead even more virulent subtypes and severe disease. It has been estimated that EHEC causes 2.8 
million illnesses, leads to 3,890 cases of HUS and 230 deaths annually worldwide [2]. Th e global 
burden of Salmonella is higher than that of EHEC, with an estimated 93.8 million infections and 
155,000 deaths each year [1]. In order to effi  ciently detect and prevent human Salmonella and 
EHEC infections, the development of rapid and sensitive subtyping methods is important. In the 
outbreak situations subtyping results of human and non-human strains should be comparable 
using standardized protocols.
6.1  Occurrence of domes? cally acquired Salmonella and EHEC 
infec? ons
In Finland, as in many other countries, Salmonella is, aft er Campylobacter, the second most 
common cause of foodborne infections. During 2007-2014, about 85% of all notifi ed salmonellosis 
cases in Finland were travel-related and the annual incidence of domestically acquired 
Salmonella infections was low varying between 5.4 and 7.5/100,000 population, depending on 
how many domestic outbreaks were annually reported. Th e low salmonella incidence among the 
Finns refl ects the low incidence in domestic production animals and food [356]. Similar low 
incidence rates for domestically acquired Salmonella infections have been reported in Sweden 
[357]. Finland and Sweden had the lowest sero-incidences based on serological measurements 
of Salmonella LPS antibody in human, including asymptomatic individuals, compared to eight 
other countries included into study of Falkenhorst et al. [358].  In contrast, both Finland and 
Sweden have reported higher incidences of all culture-confi rmed (including travel-related) 
Salmonella than the EU average [58]. Low incidence among domestic and high among travel-
related infections could indicate that Finland and Sweden have the most accurate surveillance 
systems and active salmonella control programs. Th e aim of the Finnish salmonella control 
program (FSCP) is to keep the annual prevalence of Salmonella below 1% in the specimens 
collected from the animals included in the control program . Th e FSCP covers egg and meat 
(beef, pork and poultry) production and concerns all Salmonella serovars. Despite the accurate 
surveillance in Finland, about 200-300 domestically acquired human Salmonella infections are 
reported each year demonstrating that the sources of domestic Salmonella infection might be 
other than those covered by the FSCP. 
S. Enteritidis is the most common Salmonella serovar followed by S. Typhimurium worldwide 
[58, 62, 194]. In Finland, serovar Typhimurium was the most common among domestically 
acquired infections, causing 32% of human salmonellosis. However, when also taking strains 
isolated from foreign infections into account, S. Enteritidis was the most common serovar in 
Finland as well. In 2014, the number of domestic Typhimurium infections decreased 2% when 
compared to the mean value from 2011-2013. Despite a decreasing trend, about 100 domestic 
Typhimurium infections and a few outbreaks are still reported annually in Finland. Exact reasons 
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for the drop in the number of infections caused by domestic Typhimurium are unknown. S. 
Enteritidis caused 15% of human Salmonella infections in Finland and the number of reported S. 
Enteritidis has dropped 20% when compared to the mean value from 2010-2012. Many countries 
in Western Europe have witnessed a substantial decrease in Salmonella fi ndings, particularly of 
S. Enteritidis, compared to the late 1990s [359, 360]. Th e decrease is most likely a sum of several 
control methods and due to increased use of vaccines in the poultry and egg production in the 
EU [359]. However, some studies have suggested that the reduction of human S. Enteritidis and 
S. Typhimurium experienced in the EU and North America might have occurred because of the 
number of animal infections by these serovars has fallen and the proportion of infections caused 
by antigenically distinct serovars such as Dublin in cattle and S. diarizonae found in sheep, has 
risen [361]. As these serovars are either host-adapted or seldom causes of disease in humans, 
the drop of human infections generally could be explained. Also, several codes of practice for 
hygiene have been introduced to public which might have led to a better awareness of Salmonella. 
On the other hand, an increase of other serovars e.g. MDR monophasic S. Typhimurium has 
been reported in Europe, North and South America, and Asia [362-365]. However, there are 
no recognized reservoirs of S. Enteritidis or monophasic S. Typhimurium among domestic 
production animals in Finland. 
As in many other countries [2, 58], the annual incidence of EHEC in Finland has increased 
being lowest in 2008 (0.2/100,000 population) and highest in 2013 (1.8/100,000 population). In 
general, the large outbreak caused by EHEC O104:H4 -contaminated sprouts that occurred in 
Germany 2011 enhanced awareness of EHEC. As a consequence, many countries have improved 
their EHEC diagnostics towards more sensitive PCR-based methods which target stx genes 
rather than serogroup [366]. An increased proportion of detected non-O157 serotypes in some 
countries might be due to the use of novel, more sensitive methods [366, 367]. Th e exact reasons 
for the generally increasing trend of domestically acquired EHEC infections in Finland remain 
unknown but four domestic EHEC O157 outbreaks contributed into the increase in 2012-2013. 
In addition, there have been some changes in Finnish EHEC diagnostics. For example, currently 
the majority of EHEC screening is performed by a single clinical microbiology laboratory by 
a PCR-based method and EHEC is detected together with other common enteropathogenic 
bacteria without a clinical suspicion or additional request from a physician [368]. Th e PCR 
is a sensitive method which could explain at least some of the increase. Due to the sensitivity, 
occasionally the results cannot be culture confi rmed. 
6.1.1  Occurrence of S. Typhimurium, S. Enteri? dis and EHEC phage types
Historically, epidemiological subtyping of S. Typhimurium and S. Enteritidis has relied on phage 
typing.  However, this method has only limited discriminatory power and it is performed only 
by a few reference laboratories. Furthermore, in 2008 an outbreak caused by S. Typhimurium 
highlighted problems in phage typing as diff erent naming of the lysis pattern of outbreak-related 
strains hindered the outbreak investigations (U288 in Denmark, RDNC in Norway and U302 
in Sweden) [369]. Th is international outbreak was eventually recognized by MLVA typing. In 
this study, the three most common S. Typhimurium phage types among domestically acquired 
infections were DT1, U277 and DT104, accounting together 65% of the strains. Th is fi nding 
correlated with previous studies conducted in Finland in which DT1 was found to be the most 
common in Finland [370]. DT1 is endemic in Finland and it has been the most common phage 
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type since the 60’s (statistics of THL). In Sweden and Norway, hedgehogs have been associated 
with infections in children under 5 years old caused by DT1 [371, 372]. However, no association 
with the age of the patients was found in this study. Other phage types dominate in other 
countries. For example, phage types DT135 and DT9 are common in Australia [323], whereas 
DT193, DT195 and DT120 are common in Belgium [373] and DT104 in United Kingdom (UK) 
and Canada [374]. Approximately, 10% of the domestic strains were non-typable by traditional 
phage typing. In Finland, during 2007-2014, the most common S. Enteritidis phage types were 
PT8, PT1B and PT4, accounting together for 44% of the domestically acquired S. Enteritidis 
infections. In contrast to S. Typhimurium phage type DT1 which has been the most common 
phage type since the 60s [375], the most common PTs among S. Enteritidis have varied depending 
on how many domestic outbreaks have occurred annually. In the 1990s, the most commonly 
reported phage types in Finland were PT1 and PT4 [370]. Th e increase of PT1B was associated 
with an outbreak caused by precooked frozen chicken in 2012. As among S. Typhimurium, the 
occurrence of certain S. Enteritidis phage types varies between the continents. For example, PT1 
is common in the Baltic countries, Russia and Korea [79, 376] whereas PT4 is the most common 
in the Western European countries [377, 378] and PT8 in the North America [73, 74].
Th e strains of EHEC O157 (60%) dominated over non-O157 serotypes in Finland and in other 
countries [379]. In this study, the phage types PT8, PT88 and PT2 were the most common ones. 
According to previous studies, PT8 and PT2 are commonly found in Europe and they frequently 
cause outbreaks [380-383]. During the 90s PT2 was the most common in Finland [384]. Th e 
emerge of PT88 which is most commonly associated with sor+ EHEC O157:H- strains has been 
noticed previously in Finland and in some other European countries [218, 385-387].  
6.1.2  An? microbial suscep? bility of Salmonella and EHEC
Susceptibility testing against certain antimicrobials is commonly performed in clinical 
microbiology laboratories. Th e test provides important information for a clinician to choose 
optimal treatment for the patient, if needed. It is also used for surveillance purposes as a standard 
typing method. In this study, the majority of domestic S. Typhimurium and S.Enteritidis (both 
60%) strains were susceptible to all tested antimicrobials. Also, the studied EHEC strains (81%) 
were mainly susceptible to all tested antimicrobials: 96% of O157:H7/H- and 60% of non-O157 
strains. Similar results have been obtained in Spain in which 41% of non-O157 strains were 
resistant to more than one of the tested 26 antimicrobials [388]. Th e fi nding is consistent also 
with the results obtained in British Columbia where higher levels of resistance were observed 
among non-O157 than among O157 strains, althought they tested 19 antimicrobials [389]
[389]. Th e most domestic Salmonella and EHEC strains were fully susceptible to the tested 
antimicrobials. For example, 74% of DT1 strains which consided endemic phage type in Finland 
were fully susceptible to the tested antimicrobials. However, 12% of all S. Typhimurium strains 
and 7% of the EHEC strains were MDR in this study. Decreased sensitivity to ciprofl oxacin was 
rare (4.5%) among the domestic S. Typhimurium strains. In comparison to human isolates, less 
than 1% of the tested samples from domestic production animal (cattle, swine, poultry and eggs) 
were Salmonella positive and MDR was rare [95]. Interestingly, the XbaI-PFGE profi le STYM7 
which was the most common profi le among isolates from domestic infections caused by MDR 
S. Typhimurium DT104 in this study is also the most common XbaI-PFGE profi le among 
MDR DT104 infections of foreign origin [390]. Since MDR strains were detected among Finns 
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with no travel history one might speculate that at least some of the infections could be due to 
imported foods sold in supermarkets and restaurants. In Sweden, imported foods have been 
estimated to cause 6.5% of domestic Salmonella infections [46]. In addition to imported foods, 
some of the infections could be secondary infections from the patients who have traveled abroad. 
Furthermore, an association between decreased sensitivity to ciprofl oxacin and foreign travel has 
been previously suggested in Finland [391] and in Denmark [392]. Even when the antimicrobial 
susceptibility testing is not used for patient treatment purpose, it can be used for bacterial typing 
and for estimating the origin of the infections.
6.2  Molecular epidemiology of domes? c S. Typhimurium 
XbaI-PFGE showed a genetic similarity of more than 70% of the studied S. Typhimurium strains. 
During the study period, STYM1 (also known STYMXB.0098), was the most common XbaI-
PGFE profi le (27%). Th is profi le was found among 6 phage types, DT1 being the most common. 
Furthermore, STYM1 divided into 12 MLVA types. 15% of the Typhimurium strains had same 
type using four diff erent subtyping methods. Th ey were susceptible to the tested antimicrobials, 
had phage type DT1, XbaI-PFGE profi le STYM1 and MLVA type 3-16-NA-NA-0311. Th is lack 
of diversity may suggest that these strains originated from the same reservoir or source. In 
comparison, DT1 with XbaI-PFGE profi le STYM1 caused 66% of human infections in 2000-
2003 in Finland [370]. Th is particular XbaI-PFGE and MLVA type has been associated with 
cattle, wild birds and hedgehogs in Finland [375, 393, 394]. In agreement with these results, the 
same DT1 with MLVA type 3-16-NA-NA-0311 has been isolated from hedgehogs in Sweden 
and Norway where it has been linked to infections among children [371, 372]. In this study, no 
association with age and DT1 infections was detected. 
One third of the domestic S. Typhimurium strains were of MLVA type 3-16-NA-NA-0311. Th is 
particular MLVA type was divided into seven phage types and 19 XbaI-PFGE profi les. Moreover, 
MLVA types with a single locus diff erence to type 3-16-NA-NA-0311 occurred making cluster 
defi nition challenging. Th is was demonstrated in the minimum spanning tree of MLVA types 
as domestic S. Typhimurium strains showed no particular clustering but instead they formed 
a “stardust” shaped picture. Th is might indicate that there a common reservoirs in Finland. 
In comparison to the situation in Finland, more diversity among S. Typhimurium has been 
observed by MLVA elsewhere [323, 395, 396].  
Th e most common phage types in Finland are rather homogenious and thus diffi  cult to subtype 
using PFGE or MLVA. Molecular subtyping by XbaI-PFGE or MLVA alone or both together 
were not discriminatory enough for the further characterization of the endemic infections 
caused by DT1. Th us, the sources of DT1 infections remained unidentifi ed. In particular, the lack 
of MLVA loci STTR6 and STTR10p among domestic S. Typhimurium strains diminished the 
discriminatory power of MLVA. Similar to our fi nding, the absence of loci STTR6 and STTR10p 
has been previously reported by other researchers [395, 397]. Despite lacking information for 
two MLVA loci, a diversity index of 0.891 (CI 95% 0.845-0.925) was calculated for MLVA. Th e 
source of sporadic human infections remained unknown. 
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6.3  Epidemiology of domes? cally acquired EHEC 
In Finland, the epidemiological typing of EHEC relies on a combination of pheno- and 
genotyping methods including O:H-serotyping, phage typing of O157:H7 strains, XbaI-PFGE 
and virulence gene profi ling. Th ese methods are internationally standardized and nationally and 
internationally comparable [288, 310, 311]. 
Of all O157 strains studied, more than 30% were sor+ and non-motile, as in Germany [398]. In 
this study, all sor+ O157:H-  strains carried the virulence gene combination stx2, eae and hlyA. 
Sor+ O157:H-  strains were suggested to have caused three outbreaks in Finland of which one 
outbreak was associated with a visit to cattle farm and/or consumption of unpasteurized milk 
[195]. Previous studies have implicated that cattle or cattle products occasionally harbor sor+ 
O157:H−, although the primary reservoir for this serotype is unknown [399]. 
In this 7-year study (2007-2014), about 40% of the strains belonged to non-O157 serotypes. In 
comparison, the proportion of non-O157 serotypes was 47% in 1998-2002 [197]. Th is diff erence 
might be due to O157-related outbreaks that occurred in Finland during the study period. Th e 
most common non-O157 serotypes in Finland were O26:H11/H-, O103:H2 and O145:H28/H. 
Th ese non-O157 serotypes are common in other countries as well [366, 381]. Furthermore, the 
strains of the serogroups O26, O103 and O145 have been associated with severe disease and HUS 
in Finland and elsewhere [202, 207, 367], particularly the strains of the serotype O26:H11/H- 
have been linked with HUS [400]. Despite the fact that 40% of the domestic EHEC infections 
were caused by non-O157 serotypes and that some non-O157 serotypes have been detected 
in feces of domestic cattle [401], the non-O157 strains were not associated with outbreaks in 
Finland. Non-O157 strains have been a growing concern as in several countries: they have been 
identifi ed as a signifi cant cause of disease, including HUS, and it has been suggested that their 
incidence may exceed that of EHEC O157 [6, 155, 212, 367]. 
EHEC O157 does not generally ferment sorbitol. Th us, this biochemical feature is used for 
the detection of these bacteria in many laboratories in culturing on sorbitol-MacConkey agar 
(SMAC). Th us the detection of sor+ EHEC strains remains complex and the strains of sor+ 
O157:H- and the majority of non-O157 are still estimated to be under-diagnosed [402, 403]. 
In addition, sor- non-O157 strains were identifi ed in this study. Four sor- strains belonging to 
serotypes O121:H19, O117:H7 and ONT:H49 were found. Such strains are rare but they have 
been identifi ed, for example, in Japan [404]. In 2009, EHEC O78:H-:stx1c:hlyA was detected in 
blood and stool samples of a neonate in Finland. Th is serotype had not been detected prior to 
this family outbreak and bacteraemia caused by EHEC is extremely rare. A recent study reported 
bacteraemia caused by EHEC O128ab:H2 as well [221]. In comparison to our fi nding, EHEC 
O128ab:H2 was isolated from a 27-year old male and it carried both stx1 and stx2 as well as hlyA 
genes. Th is fi nding emphasizes the importance of early detection of EHEC infections caused by 
non-O157 strains. Furthermore, these fi ndings highlight the diversity of EHEC strains and the 
need for diagnostic methods that detect both sor+ and sor- EHEC strains.
6.3.1  Virulence proper? es of EHEC
Virulence gene profi ling (stx1, stx2, eae, hlyA and saa) was used for the characterization of the 
EHEC strains. Since Shiga toxin 2 has been associated with more severe outcomes of disease 
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and HUS early characterization of a virulence profi le can provide valuable information about 
potential disease severity [243, 405]. Furthermore, the gene profi les can be used as a subtyping 
method to cluster strains [406]. Of the sor+ O157:H- strains, all were found to carry only stx2, 
similar to previous studies in Finland [218] and elsewhere [166, 385, 407]. In contrast to sor+ 
O157:H-, 65% of the sor- O157:H7 strains carried the stx2 gene in combination with stx1 in this 
study. Th is fi nding is in agreement with results from other studies [246, 408]. On the other hand, 
some studies have reported that only 30-40% of the studied sor- O157:H7 strains contained both 
stx genes [409, 410]. None of the domestic sor+ or sor- O157 strains carried the stx1 gene only or 
the saa gene. Virulence profi les in non-O157 strains displayed more variability than O157 strains. 
In this study, the non-O157 strains were divided into eight diff erent virulence gene profi les, most 
commonly in the following combinations stx1, eae, hlyA (43%) or stx2, eae, hlyA (30%), similar to 
previous studies [366, 411]. However, dominance of stx2 among non-O157 strains has also been 
detected as about half of the studied strains carried only stx2 [381]. According to some studies, the 
carriage of the stx1 gene only was the most common among O26:H11 and O103:H2 [409, 412]. 
Th is is in line with the results of this present study in which 69% of the O26:H11 and 100% of the 
O103:H2 strains carried only the stx1 gene. However, a recent report from UK has shown that the 
majority of the O26 strains carry both the stx1 and stx2 genes [366] or stx2 only in Poland [413]. In 
Finland, such a shift  in the virulence gene profi le of the O26 strains was not detected. Although 
the carriage of only stx1 was common among non-O157 in this study, all strains of O145:H28/H- 
carried only stx2 gene. Similar result for O145 has been reported [381] but in another study stx1 
has been also detected [409]. About 15% of the strains of non-O157 serotypes were eae and hlyA 
negative, in contrast to the O157:H7 strains which all carried the genes eae and hlyA. Although 
intimin has been recognized as an important adhesion protein among EHEC, strains lacking eae 
might be even more virulent and possess another mechanism for colonization as was evident in 
the large German outbreak caused by eae-negative EHEC O104:H4 [277]. Previously, the saa 
gene, responsible for producing autoagglutinating adhesin, has been associated in development 
of HUS [264]. In this study, however, only one EHEC strain (ONT:H-) carried saa gene. It is 
important to note that the 5-plex PCR [281] used in this study does not detect all stx, eae and 
hlyA variants found in EHEC.
6.4  Usefulness of tradi? onal and newer methods in surveillance 
(I, II, III and IV)
Th e goal of any typing method is to characterize bacterial strains and group the strains together 
in a way that is epidemiologically useful. Rapid and eff ective typing is needed for laboratory-
based surveillance and detection of beginning outbreaks. Strains with identical subtypes are 
more likely to be associated with a common source than those with diff erent typing profi les. Th e 
most important criteria for a subtyping method are typeability, reproducibility, discriminatory 
power and epidemiological concordance. Additional criteria include speed, low costs and ease of 
interpretation. Since none of the subtyping methods will fulfi ll all the criteria, compromises must 
be made and a combination of methods should be selected. New typing methods such WGS has 
been used surveillance and outbreak investigation [414]. Althought WGS provides the ultimate 
typing resolution and will replace some traditional methods in the near future, it is still important 
to maintain the know-how of traditional methods and comparability between the methods.
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6.4.1  Evalua? on of phenotyping methods
Serotyping, phage typing and antimicrobial susceptibility testing are important traditional 
subtyping methods for Salmonella and EHEC, and are all internationally standardized methods. 
Serotyping has proven to be a robust and reproducible method for both bacteria [415]. For over 
70 years serotyping has been an important method in public health monitoring. Th e advantages 
of serotyping include ease of performance and good epidemiological concordance. Some 
Salmonella serovars are host-specifi c or occur in certain geographical regions or continents [416] 
whereas serotype results of EHEC can give important information about the source of infection 
or severity of the infection [307]. However, slide agglutination is time-consuming and expensive 
antisera of good quality are required. Additional subtyping is required for the most common 
Salmonella serovars and EHEC serotypes. Phage typing, for example, is a traditional subtyping 
method for Salmonella serovars Typhimurium [285], Enteritidis [286] and for EHEC O157 
[288]. It is cheap but non-typeable strains do occur. In this study, non-typeable strains were 
detected among the strains of S.Typhimurium (16%). Furthermore, phage typing is not always 
reproducible between laboratories. For example, an international outbreak has been hindered 
due to diff erent phage type interpretation between countries [289]. In addition, phage typing 
has limited discriminatory power and it requires specifi c phage collection [417]. Still, phage 
typing is a valuable tool for the fi rst quick evaluation of potential outbreaks, especially for less 
common phage types, and for identifying strains related to certain countries or sources [292, 
293]. In particular, when phage typing results are combined with results of other typing method 
such as PFGE or MLVA a good epidemiological concordance can be achieved. Antimicrobial 
susceptibility testing is also important traditional typing method which has been applied 
for routine typing and to understand source and transmission dynamics of resistant strains 
[418]. Th e method is cheap, simple and does not require specifi c equipment. Th e drawbacks 
include poor discriminatory power and instability of certain resistance factors under selective 
pressure or during storage [294]. Furthermore, there is a lack of harmonization in terms of 
antimicrobials tested and criteria used for interpretation, in particularly between human and 
veterinary laboratories [295]. Nevertheless, epidemiological antimicrobial susceptibility testing 
is widely used. Since the majority of domestic Salmonella and EHEC in Finland are susceptiple 
to antimicrobials this method gives information about the potential foreign origin of the studied 
strain if it contains resistance markers. 
Novel phenotyping methods that are not internationally harmonized can be applied for the 
characterization of foodborne Salmonella and EHEC strains or research [297]. Phenotyping 
microarray (PM) plates with various substances can be used to study the ability of bacteria to 
metabolize certain compounds [419]. Diff erences in the metabolic profi le might be characteristic 
of new clones or hybrids or genetic features. For example, PM analysis of the EHEC O157:H7 
strain related to a spinach outbreak in the USA showed a rare N-acetyl-d-galactosamine-negative 
phenotype, which had only been found once before [298]. Variation in motility and biofi lm 
formation of S. Typhi has been studied using the PM method [420]. However, in this study PM 
technology was applied only for certain Salmonella strains. Th e PM results were reproducible but 
only a few metabolic diff erences were found between diff erent Salmonella serovars. Th erefore, 
PM is not useful method for grouping Salmonella strains in epidemiologically meaningful way. 
For routine surveillance of foodborne pathogens the PM technology is too expensive.
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6.4.2 Comparison of PFGE and MLVA methods
PFGE has been shown to be a highly discriminatory genotyping method for subtyping of 
Salmonella and EHEC isolates and it has been considered as “gold standard” [309, 311]. Th e 
advantages of PFGE include that it is robust and internationally standardized. Futhermore, the 
naming of the PFGE profi les is harmonized and the most common profi les or profi les associated 
with outbreaks have international names [390]. However, identifi cation of infection clusters and 
source tracking by PFGE are complicated by common and widely distributed PFGE profi les [421, 
422]. Furthermore, PFGE is a labor-intensive and time-consuming technique and results might 
be challenging to interpret [309, 312]. Th e XbaI restriction enzyme is typically used as a primary 
enzyme for determining genetic relatedness of Salmonella and EHEC strains and BlnI can be 
used to either confi rm XbaI results or to provide additional resolution [423]. For example, XbaI-
PFGE has showed only limited discrimination for S. Enteritidis but the use of multiple restriction 
enzymes can increase the discriminatory power of PFGE [424]. However, in agreement with 
previous studies [310, 311, 316]. only XbaI was used in this study for PFGE analysis for both 
Salmonella and EHEC. In this study, relatively high discriminatory ability of XbaI was observed 
for S. Typhimurium (DI>0.8). Futhermore, the XbaI-PFGE analysis was used for investigation 
of outbreak caused by S. Newport/S. Reading in Finland. All studied S. Newport strains had 
indistinguishable XbaI-PFGE profi les whereas four distict XbaI-PFGE profi les for S. Reading 
(SREA4-7) were detected. Th e diff erences in the PFGE profi les of the outbreak-related strains are 
thought to be due to point mutations, inserts and deletions in the genome or loss or acquisition of 
a plasmid [309]. Since the profi les SREA4 and SREA7 diff ered by more that 10 banding position 
it is likely that the vehicle (iceberg salad) had been contaminated with S. Reading with diverse 
genotypes. One might also expect that if fi ve or more colonies per patient had been investigated 
even more genotypic variation might have been observed. Only four outbreaks caused by EHEC 
were detected but in two of them an identical Xbal-PFGE profi le 1.203 occurred. Still, no for all 
cases common source or transmission route was identifi ed. Th e most domestic EHEC infections 
were sporadic or related to family clusters, as in other studies [197, 209]. In recent outbreak 
investigations and research studies, PFGE results have been complemented with MLVA [320, 
425]
Molecular techniques like MLVA are generally considered to improve surveillance and detection 
of outbreaks and their sources [373, 406].  In this study, the discriminatory power of MLVA 
was equel to Xbal-PFGE among the strains of S. Typhimurium. However, compared to PFGE, 
MLVA is faster, cheaper and the interpretation of the results is unambiguous [322] but the time 
required and cost per strain depends on the fragment analysis platform and equipment used. Th e 
possibility of sharing MLVA results across country borders as a string of fi ve to seven numbers is 
one of the strengths of MLVA. Although an increasing number of studies indicate that MLVA can 
provide improved discrimination, only two MLVA protocols, namely, for S. Typhimurium [322] 
and S. Enteritidis [292, 325], have been harmonized in the EU. Th erefore, PFGE still remains 
the best choice for the remaining Salmonella serovars and EHEC. Alhought not used in this 
study, MLVA for S. Enteritidis and EHEC O157 have been widely used [377, 406]. In the near 
future WGS will most propably replace PFGE and MLVA. Althought, MLVA is as sensitive as 
WGS, WGS provides an ultimate resolution and more information at one run [426]. Even the 
serotyping of Salmonella which was earlier thought to be a limitating factor in utilization of WGS 
has been solved as a free soft ware which recognizes more than 2,300 serovars was launched at the 
beginning of 2015 [427]. 
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7 CONCLUSIONS AND FUTURE CONSIDERATIONS
In this thesis, knowledge of microbiological pheno- and genotypic characteristics of human 
Salmonella and EHEC strains isolated from domestically acquired infections in Finland was 
obtained. During 2007-2014, 2,818 microbiologically confi rmed Salmonella infections and 188 
EHEC infections were characterized. Only 15% of all microbiologically confi rmed Salmonella but 
70% of all EHEC infections were considered domestically acquired. Th e number of domestically 
acquired Salmonella infections decreased about one fi ft h compared to the previous decade 
whereas the number of domestic EHEC infections increased about one third. Th e incidence 
of domestic Salmonella infections was highest in 2012 (7.5/105 population) and lowest in 2014 
(5.4/105 population). Th e incidence of domestic EHEC infections was highest in 2013 (0.33/105 
population) and lowest in 2008 (0.07/105 population). 
1. Th e most common Salmonella serovars were Typhimurium (32%), Enteritidis (15%) and 
Group B (6%). EHEC serotype O157:H7/H- dominated in Finland (60%). Th e most common 
non-EHEC serotypes were O26:H11/H-, O103:H2/H- and O145:H28/H-.
2. More than 60% of all domestic S. Typhimurium and strains were fully susceptible against 
12 tested antimicrobials. Th e majority of domestic EHEC strains (81%) were susceptible to 
all tested antimicrobials, more specifi c, 96% of the O157:H7/H- and 60% of the non-O157 
strains. 
3. MLVA provided an inexpensive, high-throughput, discriminatory and accurate typing 
method for the surveillance of S. Typhimurium. Th e results were easy to compare between 
laboratories. 
4. Th e discriminatory power of MLVA was reduced because 70% of the domestic S. 
Typhimurium strains lacked MLVA loci STTR6 and STTR10p. Still, the calculated 
discriminatory power was equally high (DI≥0.8) for PFGE and MLVA methods. Since 
January 2013, MLVA has been the primary genotyping method for S. Typhimurium at THL. 
In outbreak situations or if needed for clarifi cation, MLVA results can by complemented 
with PFGE (or in the future with WGS) at THL.
5. About 15% of the sporadic S. Typhimurium strains were of identical type with four diff erent 
typing methods. Th ey were susceptible to 12 antimicrobials, of phage type DT1, XbaI-PFGE 
profi le STYM1 (STYMXB.0098) and MLVA type 3-16-NA-NA-0311.
6. Domestic EHEC non-O157 strains showed more variability in the virulence gene profi les 
than EHEC O157 strains. All O157 strains carried stx2 (40% in combination with stx1), eae 
and hlyA genes. In contrast, 55% of the non-O157 stains had stx1 gene and 76% carried eae 
and hlyA genes and only one strain had saa gene.
7. In many cases the sources and transmission routes of the domestic infections caused by 
Salmonella and EHEC remained undetermined. However, some of the domestic Salmonella 
infections were associated with contaminated imported foodstuff s such as pre chopped 
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lettuce (S. Newport/S. Reading, 2008), imported sprout seeds (S. Bovismorbifi cans, 2009) and 
precooked chicken cubes (S. Enteritidis, PT1B, 2012). Only EHEC serotype O157:H7/H- was 
associated with outbreaks in Finland. In one of the outbreaks, consumption of unpasteurized 
milk or animal contact was the source of the infections. 
8. In 2009, a rare EHEC O78:H-:stx1c: hlyA was detected in blood and stool samples of a 
2-week-old neonate who had bacteremia and HUS. Th e strain was also found in the stool 
samples of his asymptomatic family members. Th is fi nding emphasizes the importance of 
early detection of EHEC infections caused by non-O157 strains especially in young children. 
Salmonella and EHEC infections pose a major public health concern and they cause substantial 
costs to society. Although the overall number of Salmonella infections has decreased in Finland, 
the number of certain Salmonella serovars (e.g. monophasic S. Typhimurium) and EHEC has 
increased. In order to detect and prevent outbreaks and limit the spread of infections, accurate 
and cost-eff ective typing methods are of importance. New typing methods are being developed 
for Salmonella and EHEC and in the near future they probably will replace many traditionally 
used methods. For example, WGS is getting an increasingly attractive method for routine 
surveillance of both the pathogens studied in this research because costs for sequencing have 
dropped, bench-top sequencing machines enable fast typing and user friendly soft ware and web-
based tools do exist. However, although typing by WGS provides a high resolution, as with any 
typing method it is important to remember that additional epidemiological information is still 
necessary for correct interpretation of the results. 
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